| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH3 MYH10 MYO10 STARD9 KIF5A DNAH5 DNAH8 DNHD1 MYO18A DNAH11 | 4.44e-07 | 118 | 208 | 10 | GO:0003774 |
| GeneOntologyMolecularFunction | actin filament binding | MYH3 MYH10 MYO10 SPTAN1 ACTN2 TLN2 CNN1 SYNE1 CAPZA1 CAPZA2 MYO18A MACF1 | 4.88e-06 | 227 | 208 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH3 MYH10 CENPF MYO10 BCAS3 SPTAN1 OBSCN ACTN2 ADGRV1 TUBGCP4 EPB41L3 BRCA2 STARD9 SUN2 TLN2 KIF5A CNN1 SYNE1 CAPZA1 CAPZA2 NUMA1 MYO18A APC OPA1 SPAG5 MACF1 APPL1 CEP295 | 1.10e-05 | 1099 | 208 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH3 MYH10 ERCC6 MYO10 ZGRF1 BCS1L LONP1 STARD9 KIF5A DNAH5 DNAH8 DNHD1 CECR2 MYO18A CHD7 SMC2 MACF1 DHX34 DNAH11 | 2.46e-05 | 614 | 208 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.12e-05 | 18 | 208 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.95e-05 | 70 | 208 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | MYO10 BCAS3 OBSCN DAB2 ACTN2 OSBPL8 NPM1 PITPNM2 PIGK NUMA1 APPL1 SNX1 | 1.25e-04 | 316 | 208 | 12 | GO:0035091 |
| GeneOntologyMolecularFunction | tubulin binding | CENPF BCAS3 TUBGCP4 BRCA2 STARD9 SUN2 KIF5A NUMA1 APC OPA1 SPAG5 MACF1 APPL1 CEP295 | 1.67e-04 | 428 | 208 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | dynein complex binding | 1.92e-04 | 28 | 208 | 4 | GO:0070840 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.92e-04 | 28 | 208 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule binding | CENPF TUBGCP4 STARD9 SUN2 KIF5A NUMA1 APC OPA1 SPAG5 MACF1 CEP295 | 4.04e-04 | 308 | 208 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 4.62e-04 | 15 | 208 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.77e-04 | 37 | 208 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | phospholipid binding | MYO10 BCAS3 OBSCN DAB2 ACTN2 OSBPL8 NPM1 PITPNM2 AMPH PIGK NUMA1 APOB OPA1 APPL1 SNX1 | 6.53e-04 | 548 | 208 | 15 | GO:0005543 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 ERCC6 BCS1L LONP1 KIF5A DNAH5 DNAH8 MYO18A CHD7 SMC2 MACF1 DHX34 DNAH11 | 7.61e-04 | 441 | 208 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.06e-03 | 5 | 208 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MCIDAS HAUS3 ODAD4 TUBGCP4 LRRC43 NEFL BRCA2 STARD9 SUN2 KIF5A DNAH5 DNAH8 CHMP4C NPM1 DNHD1 SEMG1 LCA5 CDC42BPA NUMA1 APC APOB CEP192 SIK3 OPA1 SPAG5 MEGF8 SASS6 MACF1 CEP295 POLDIP2 PCM1 PCNT DNAH11 | 5.60e-09 | 1058 | 206 | 33 | GO:0007017 |
| GeneOntologyBiologicalProcess | nucleus localization | 2.51e-07 | 44 | 206 | 7 | GO:0051647 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MCIDAS HAUS3 ODAD4 TUBGCP4 LRRC43 NEFL BRCA2 STARD9 SUN2 DNAH5 DNAH8 CHMP4C NPM1 CDC42BPA NUMA1 APC CEP192 SIK3 SPAG5 SASS6 CEP295 POLDIP2 PCM1 PCNT | 2.51e-07 | 720 | 206 | 24 | GO:0000226 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH3 MYH10 CENPF MCIDAS OBSCN HAUS3 ACTN2 TUBGCP4 MYLK3 STARD9 CHMP4C NPM1 NUMA1 CEP192 SPAG5 SASS6 CEP295 MYOM2 POLDIP2 | 3.25e-07 | 475 | 206 | 19 | GO:0140694 |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 MYH10 CENPF MCIDAS OBSCN HAUS3 ODAD4 ACTN2 TUBGCP4 LRRC43 FBXW8 MYLK3 STARD9 DNAH5 DNAH8 CHMP4C NPM1 DNHD1 CEP162 SYNE1 NUMA1 CEP192 SPAG5 MTOR LRRTM2 SASS6 CEP295 MYOM2 POLDIP2 PCM1 PCNT | 3.54e-07 | 1138 | 206 | 31 | GO:0070925 |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 2.29e-06 | 39 | 206 | 6 | GO:1905508 | |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 3.08e-06 | 63 | 206 | 7 | GO:0044380 | |
| GeneOntologyBiologicalProcess | organelle localization | CDK9 MYH10 CENPF NEFL BRCA2 SUN2 PDZD8 KIF5A MUL1 CHMP4C NPM1 CDC42BPA SYNE1 NUMA1 APC MYZAP OPA1 SPAG5 MTOR NDRG4 PCM1 | 8.14e-06 | 703 | 206 | 21 | GO:0051640 |
| GeneOntologyBiologicalProcess | spindle organization | HAUS3 TUBGCP4 STARD9 SUN2 CHMP4C NUMA1 CEP192 SPAG5 SASS6 POLDIP2 PCNT | 1.65e-05 | 224 | 206 | 11 | GO:0007051 |
| GeneOntologyBiologicalProcess | nuclear migration | 2.08e-05 | 34 | 206 | 5 | GO:0007097 | |
| GeneOntologyBiologicalProcess | spindle assembly | HAUS3 TUBGCP4 STARD9 CHMP4C NUMA1 CEP192 SPAG5 SASS6 POLDIP2 | 2.39e-05 | 153 | 206 | 9 | GO:0051225 |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 2.68e-05 | 59 | 206 | 6 | GO:0072698 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH3 MYH10 OBSCN ACTN2 EPB41L3 MYLK3 CNN1 CDC42BPA MYO18A MTOR MYOM2 | 3.00e-05 | 239 | 206 | 11 | GO:0031032 |
| GeneOntologyBiologicalProcess | protein localization to organelle | CDK9 OBSCN SRP68 ODAD4 BCS1L BRCA2 SUN2 OSBPL8 IMMP1L GOLGB1 NPM1 IPO7 KALRN SYNE1 NUMA1 APC CEP192 SPAG5 FAM83H SLF2 MTOR SRGN MACF1 APPL1 PCM1 DNAH11 | 3.54e-05 | 1091 | 206 | 26 | GO:0033365 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 3.56e-05 | 62 | 206 | 6 | GO:0032786 | |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 3.63e-05 | 38 | 206 | 5 | GO:0071539 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | HAUS3 CHMP4C NPM1 SEMG1 NUMA1 APC CEP192 SPAG5 SASS6 MACF1 CEP295 DNAH11 | 4.10e-05 | 293 | 206 | 12 | GO:0032886 |
| GeneOntologyBiologicalProcess | positive regulation of spindle assembly | 5.30e-05 | 8 | 206 | 3 | GO:1905832 | |
| GeneOntologyBiologicalProcess | chromosome segregation | CENPF HAUS3 TUBGCP4 BRCA2 ANAPC1 STARD9 CHMP4C NUMA1 APC CEP192 SMC2 SPAG5 SASS6 POLDIP2 TOP1 | 7.18e-05 | 465 | 206 | 15 | GO:0007059 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 8.15e-05 | 179 | 206 | 9 | GO:0031023 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DAB2 IKZF1 ACTN2 ZNF804A NEFL FBXW8 MYLK3 MUL1 CACNA1B DDR1 AMPH KALRN SYNE1 NUMA1 MYO18A APC SMC2 OPA1 SPAG5 MEGF8 SLF2 MTOR LRRTM2 SASS6 MACF1 APPL1 CEP295 POLDIP2 NDRG4 | 9.73e-05 | 1366 | 206 | 29 | GO:0051130 |
| GeneOntologyBiologicalProcess | transcription elongation-coupled chromatin remodeling | 1.12e-04 | 10 | 206 | 3 | GO:0140673 | |
| GeneOntologyBiologicalProcess | cell junction organization | MYH10 PCDHB5 ACTN2 EPB41L3 ZNF804A NEFL TJP2 TLN2 CACNB3 PCDHGC5 KALRN CAPZA1 CPEB3 APC LAMB2 DGKZ OPA1 LRRTM2 MACF1 APPL1 POLDIP2 CDH8 CACNA2D3 | 1.18e-04 | 974 | 206 | 23 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 1.22e-04 | 26 | 206 | 4 | GO:0046599 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | MCIDAS CHMP4C NPM1 SYNE1 NUMA1 CEP192 SPAG5 MTOR LRRTM2 SASS6 CEP295 | 1.24e-04 | 280 | 206 | 11 | GO:1902115 |
| GeneOntologyBiologicalProcess | microtubule-based movement | ODAD4 NEFL STARD9 SUN2 KIF5A DNAH5 DNAH8 DNHD1 SEMG1 LCA5 APOB OPA1 MEGF8 PCM1 DNAH11 | 1.37e-04 | 493 | 206 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | centrosome duplication | 1.61e-04 | 81 | 206 | 6 | GO:0051298 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 1.68e-04 | 52 | 206 | 5 | GO:0010824 | |
| GeneOntologyBiologicalProcess | centriole assembly | 1.84e-04 | 53 | 206 | 5 | GO:0098534 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CDK9 MYH10 CENPF MCIDAS TUBGCP4 BRCA2 ANAPC1 SUN2 CHMP4C ZNRD2 NUMA1 APC DGKZ CEP192 SMC2 CREB3L1 SPAG5 USP2 ASCL1 SASS6 APPL1 POLDIP2 PCNT | 2.12e-04 | 1014 | 206 | 23 | GO:0000278 |
| GeneOntologyBiologicalProcess | myofibril assembly | 2.23e-04 | 86 | 206 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 2.40e-04 | 253 | 206 | 10 | GO:0099111 | |
| GeneOntologyBiologicalProcess | cell cycle process | MYH10 ERCC6 TRIM75 CENPF HAUS3 TUBGCP4 BRCA2 ANAPC1 STARD9 SUN2 CHMP4C NPM1 CECR2 NUMA1 APC DGKZ CEP192 SMC2 CREB3L1 SPAG5 SLF2 SASS6 APPL1 CEP295 POLDIP2 CSPP1 TOP1 PCM1 PCNT | 2.42e-04 | 1441 | 206 | 29 | GO:0022402 |
| GeneOntologyBiologicalProcess | centrosome cycle | 2.49e-04 | 164 | 206 | 8 | GO:0007098 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 2.69e-04 | 89 | 206 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 2.91e-04 | 127 | 206 | 7 | GO:0006368 | |
| GeneOntologyBiologicalProcess | nuclear matrix anchoring at nuclear membrane | 2.96e-04 | 3 | 206 | 2 | GO:0090292 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 3.06e-04 | 59 | 206 | 5 | GO:0045214 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CDK9 CDK18 ERCC6 CENPF MCIDAS BRCA2 ANAPC1 CHMP4C NPM1 IPO7 NUMA1 APC DGKZ CEP192 SMC2 CREB3L1 TFDP2 SPAG5 USP2 SLF2 ASCL1 SASS6 APPL1 CEP295 POLDIP2 CSPP1 | 3.40e-04 | 1256 | 206 | 26 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 3.42e-04 | 93 | 206 | 6 | GO:0034243 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 3.54e-04 | 34 | 206 | 4 | GO:0090169 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SMG1 CENPF BCAS3 MCIDAS SPTAN1 HAUS3 ACTN2 MYLK3 ANAPC1 MUL1 CHMP4C NPM1 CACNA1B SYNE1 CAPZA1 CAPZA2 NUMA1 APC CEP192 SMC2 OPA1 SPAG5 SLF2 MTOR LRRTM2 SASS6 CEP295 | 4.05e-04 | 1342 | 206 | 27 | GO:0033043 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYH10 CENPF NEFL BRCA2 SUN2 KIF5A CHMP4C NPM1 CDC42BPA SYNE1 NUMA1 APC OPA1 SPAG5 PCM1 | 4.08e-04 | 546 | 206 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in determination of left/right asymmetry | 4.09e-04 | 15 | 206 | 3 | GO:0060287 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 4.16e-04 | 63 | 206 | 5 | GO:0046605 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | MYH10 MYO10 MCIDAS ODAD4 ACTN2 LRRC43 FBXW8 DNAH5 DNAH8 DNHD1 CEP162 SYNE1 APC MTOR ARHGEF26 PCM1 PCNT | 4.22e-04 | 670 | 206 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | intracellular transport | SMG1 MYH10 MYO10 DAB2 ACTN2 NUP205 NEFL TGFBRAP1 SUN2 KIF5A HERC2 SEC23B CHMP4C NPM1 LCA5 CDC42BPA IPO7 SYNE1 NUMA1 OPA1 SPAG5 IWS1 SLC51B UPF2 APPL1 NDRG4 SNX1 PCM1 PCNT | 4.49e-04 | 1496 | 206 | 29 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | CDK9 MYH10 DAB2 ACTN2 LRIG2 NPM1 CACNB3 IPO7 KALRN NUMA1 MYO18A APC CEP192 SIK3 SPAG5 IWS1 SLC51B MTOR PDE8B APPL1 CEP295 NDRG4 RFPL2 PCM1 PCNT | 4.69e-04 | 1212 | 206 | 25 | GO:0060341 |
| GeneOntologyBiologicalProcess | neuron projection development | MYH10 ERCC6 DAB2 ADGRV1 EPB41L3 ZNF804A LRIG2 NEFL FBXW8 KIF5A MUL1 DDR1 KALRN SYNE1 CECR2 CPEB3 APC LAMB2 APLP1 OPA1 MEGF8 MTOR MACF1 ANKRD24 NDRG4 SNX1 | 4.80e-04 | 1285 | 206 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell projection assembly | MYH10 MYO10 MCIDAS ODAD4 ACTN2 LRRC43 FBXW8 DNAH5 DNAH8 DNHD1 CEP162 SYNE1 APC MTOR ARHGEF26 PCM1 PCNT | 5.42e-04 | 685 | 206 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 5.88e-04 | 4 | 206 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 6.20e-04 | 144 | 206 | 7 | GO:0006354 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 6.54e-04 | 105 | 206 | 6 | GO:0032784 | |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 7.22e-04 | 107 | 206 | 6 | GO:0051310 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | BCAS3 SPTAN1 HAUS3 ACTN2 MYLK3 CHMP4C NPM1 CAPZA1 CAPZA2 NUMA1 APC SPAG5 MTOR SASS6 CEP295 | 7.46e-04 | 579 | 206 | 15 | GO:0051493 |
| GeneOntologyCellularComponent | centriole | CEP170 FBXW8 CEP78 STARD9 CROCC2 HERC2 CEP162 CEP192 SASS6 CEP295 PCM1 PCNT | 1.61e-07 | 172 | 208 | 12 | GO:0005814 |
| GeneOntologyCellularComponent | microtubule | BCAS3 HAUS3 TUBGCP4 ZNF804A CEP170 KIF5A DNAH5 DNAH8 CHMP4C CEP162 NUMA1 APC OPA1 SPAG5 MACF1 CEP295 CSPP1 PCNT DNAH11 | 1.73e-06 | 533 | 208 | 19 | GO:0005874 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH3 MYH10 BCAS3 SPTAN1 OBSCN HAUS3 ACTN2 TUBGCP4 ZNF804A CEP170 NEFL KIF5A DNAH5 DNAH8 CHMP4C CEP162 SYNE1 NUMA1 MYO18A APC MYZAP OPA1 SPAG5 FAM83H MACF1 CEP295 MYOM2 CSPP1 PCNT DNAH11 | 2.13e-06 | 1179 | 208 | 30 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH3 MYH10 BCAS3 SPTAN1 OBSCN HAUS3 ACTN2 TUBGCP4 ZNF804A CEP170 NEFL KIF5A DNAH5 DNAH8 CHMP4C CEP162 SYNE1 NUMA1 MYO18A APC MYZAP OPA1 SPAG5 FAM83H MACF1 CEP295 MYOM2 CSPP1 PCNT DNAH11 | 2.44e-06 | 1187 | 208 | 30 | GO:0099081 |
| GeneOntologyCellularComponent | myosin filament | 4.20e-06 | 25 | 208 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | microtubule organizing center | CENPF HAUS3 TUBGCP4 CEP170 FBXW8 CEP78 BRCA2 STARD9 CROCC2 HERC2 NPM1 LCA5 CEP162 NUMA1 MYO18A APC CEP192 CCDC141 SPAG5 USP2 SASS6 CEP295 CSPP1 PCM1 PCNT | 5.22e-06 | 919 | 208 | 25 | GO:0005815 |
| GeneOntologyCellularComponent | 9+0 motile cilium | 1.90e-05 | 6 | 208 | 3 | GO:0097728 | |
| GeneOntologyCellularComponent | centrosome | CENPF HAUS3 TUBGCP4 CEP170 CEP78 BRCA2 CROCC2 NPM1 LCA5 CEP162 NUMA1 APC CEP192 CCDC141 SPAG5 USP2 SASS6 CEP295 CSPP1 PCM1 PCNT | 3.00e-05 | 770 | 208 | 21 | GO:0005813 |
| GeneOntologyCellularComponent | cell leading edge | MYH10 MYO10 BCAS3 MCC ADGRV1 EPB41L3 TLN2 AMPH CDC42BPA APC DGKZ MACF1 APPL1 ARHGEF26 ARHGAP45 SNX1 | 4.34e-05 | 500 | 208 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | cytoplasmic region | CENPF ODAD4 LRRC43 NEFL KIF5A DNAH5 DNAH8 DNHD1 LCA5 CEP162 NUMA1 OPA1 DNAH11 | 6.91e-05 | 360 | 208 | 13 | GO:0099568 |
| GeneOntologyCellularComponent | spindle | MYH10 TRIM75 CENPF HAUS3 TUBGCP4 CEP170 CHMP4C NPM1 CEP162 NUMA1 TFDP2 SPAG5 CEP295 POLDIP2 CSPP1 | 7.97e-05 | 471 | 208 | 15 | GO:0005819 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CENPF ODAD4 LRRC43 NEFL KIF5A DNAH5 DNAH8 DNHD1 LCA5 CEP162 OPA1 DNAH11 | 8.44e-05 | 317 | 208 | 12 | GO:0032838 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | BCAS3 HAUS3 ACTN2 TUBGCP4 ZNF804A CEP170 NEFL KIF5A DNAH5 DNAH8 CHMP4C CEP162 NUMA1 APC OPA1 SPAG5 FAM83H MACF1 CEP295 CSPP1 PCNT DNAH11 | 9.59e-05 | 899 | 208 | 22 | GO:0099513 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 MYH10 MYO10 SPTAN1 ACTN2 MYLK3 TLN2 CNN1 AMPH CDC42BPA KALRN CAPZA1 CAPZA2 MYO18A MYZAP MACF1 | 2.23e-04 | 576 | 208 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | axoneme | 2.38e-04 | 207 | 208 | 9 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.46e-04 | 208 | 208 | 9 | GO:0097014 | |
| GeneOntologyCellularComponent | cell cortex | MYH10 MYO10 SPTAN1 ACTN2 OSBPL8 CAPZA1 CAPZA2 NUMA1 APC MYZAP MACF1 | 1.28e-03 | 371 | 208 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | procentriole replication complex | 1.44e-03 | 6 | 208 | 2 | GO:0120099 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.55e-03 | 269 | 208 | 9 | GO:0036464 | |
| GeneOntologyCellularComponent | midbody | 1.76e-03 | 222 | 208 | 8 | GO:0030496 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.86e-03 | 129 | 208 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.90e-03 | 25 | 208 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 2.04e-03 | 54 | 208 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 2.13e-03 | 26 | 208 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 2.33e-03 | 56 | 208 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.40e-03 | 287 | 208 | 9 | GO:0035770 | |
| GeneOntologyCellularComponent | myosin II complex | 2.65e-03 | 28 | 208 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | pericentriolar material | 2.65e-03 | 28 | 208 | 3 | GO:0000242 | |
| Domain | Spectrin | 1.29e-07 | 23 | 202 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 5.74e-07 | 29 | 202 | 6 | IPR002017 | |
| Domain | Dynein_HC_stalk | 1.22e-05 | 14 | 202 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.22e-05 | 14 | 202 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.22e-05 | 14 | 202 | 4 | PF08393 | |
| Domain | MT | 1.22e-05 | 14 | 202 | 4 | PF12777 | |
| Domain | DHC_fam | 1.65e-05 | 15 | 202 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.65e-05 | 15 | 202 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.65e-05 | 15 | 202 | 4 | IPR004273 | |
| Domain | SPEC | 2.24e-05 | 32 | 202 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.24e-05 | 32 | 202 | 5 | IPR018159 | |
| Domain | DHC_N1 | 6.71e-05 | 8 | 202 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 6.71e-05 | 8 | 202 | 3 | IPR013594 | |
| Domain | IQ | 2.46e-04 | 81 | 202 | 6 | SM00015 | |
| Domain | F_ACTIN_CAPPING_A_1 | 3.47e-04 | 3 | 202 | 2 | PS00748 | |
| Domain | F_ACTIN_CAPPING_A_2 | 3.47e-04 | 3 | 202 | 2 | PS00749 | |
| Domain | F-actin_cap_A | 3.47e-04 | 3 | 202 | 2 | PF01267 | |
| Domain | CapZ_alpha | 3.47e-04 | 3 | 202 | 2 | IPR002189 | |
| Domain | F-actin_cap_asu_CS | 3.47e-04 | 3 | 202 | 2 | IPR017865 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.16e-04 | 14 | 202 | 3 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 4.16e-04 | 14 | 202 | 3 | IPR011704 | |
| Domain | AAA_8 | 4.16e-04 | 14 | 202 | 3 | PF12780 | |
| Domain | AAA_5 | 4.16e-04 | 14 | 202 | 3 | PF07728 | |
| Domain | IQ_motif_EF-hand-BS | 4.35e-04 | 90 | 202 | 6 | IPR000048 | |
| Domain | IQ | 5.19e-04 | 93 | 202 | 6 | PS50096 | |
| Domain | Pecanex_C | 6.88e-04 | 4 | 202 | 2 | PF05041 | |
| Domain | Pecanex | 6.88e-04 | 4 | 202 | 2 | IPR007735 | |
| Domain | Myosin_head_motor_dom | 7.35e-04 | 38 | 202 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.35e-04 | 38 | 202 | 4 | PS51456 | |
| Domain | Myosin_head | 7.35e-04 | 38 | 202 | 4 | PF00063 | |
| Domain | MYSc | 7.35e-04 | 38 | 202 | 4 | SM00242 | |
| Domain | Myosin_tail_1 | 9.02e-04 | 18 | 202 | 3 | PF01576 | |
| Domain | Myosin_tail | 9.02e-04 | 18 | 202 | 3 | IPR002928 | |
| Domain | P-loop_NTPase | MYH3 MYH10 ERCC6 MYO10 ZGRF1 BCS1L LONP1 STARD9 TJP2 KIF5A DNAH5 DNAH8 DNHD1 CACNB3 MYO18A CHD7 SMC2 OPA1 DHX34 DNAH11 | 9.08e-04 | 848 | 202 | 20 | IPR027417 |
| Domain | IQ | 1.03e-03 | 71 | 202 | 5 | PF00612 | |
| Domain | Myosin-like_IQ_dom | 1.06e-03 | 19 | 202 | 3 | IPR027401 | |
| Domain | - | 1.06e-03 | 19 | 202 | 3 | 4.10.270.10 | |
| Domain | FATC | 1.14e-03 | 5 | 202 | 2 | PF02260 | |
| Domain | Ca_hom_mod | 1.70e-03 | 6 | 202 | 2 | PF14798 | |
| Domain | EFhand_Ca_insen | 1.70e-03 | 6 | 202 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.70e-03 | 6 | 202 | 2 | IPR014837 | |
| Domain | FAT | 1.70e-03 | 6 | 202 | 2 | PS51189 | |
| Domain | FATC | 1.70e-03 | 6 | 202 | 2 | PS51190 | |
| Domain | FAM26 | 1.70e-03 | 6 | 202 | 2 | IPR029569 | |
| Domain | FATC_dom | 1.70e-03 | 6 | 202 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.70e-03 | 6 | 202 | 2 | IPR014009 | |
| Domain | FATC | 1.70e-03 | 6 | 202 | 2 | SM01343 | |
| Domain | ACTININ_2 | 1.88e-03 | 23 | 202 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.88e-03 | 23 | 202 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.88e-03 | 23 | 202 | 3 | IPR001589 | |
| Pubmed | MYH10 CENPF SPTAN1 MCC EPB41L3 UBN2 CEP170 LRIG2 NEFL ANAPC1 TLN2 KIF5A HERC2 GOLGB1 NPM1 FOXP2 KALRN ZNRD2 SYNE1 CAPZA2 NUMA1 APC DGKZ CHD7 SIK3 SMC2 ZBTB1 OPA1 MTOR MACF1 APPL1 ADGRA1 ARHGEF26 PCM1 PCNT | 1.75e-17 | 963 | 211 | 35 | 28671696 | |
| Pubmed | MYH10 CENPF SPTAN1 UGGT1 SRP68 EPB41L3 NUP205 CEP170 NEFL LONP1 ANAPC1 SUPT5H OSBPL8 TJP2 HERC2 SEC23B NPM1 IPO7 NUMA1 CHD7 TGM3 MTOR MACF1 TOP1 PCM1 PCNT | 4.15e-14 | 653 | 211 | 26 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK9 CDK18 BCAS3 SPTAN1 EPB41L3 CEP170 MYLK3 STARD9 SYDE2 OSBPL8 TJP2 SEC23B GOLGB1 CDC42BPA CEP162 APC CEP192 SIK3 FAM83H ARFGEF3 FAM13A MEGF8 SLF2 MTOR MACF1 CSPP1 PCM1 SAMD4A | 5.71e-13 | 861 | 211 | 28 | 36931259 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTAN1 KCNB2 EPB41L3 NEFL TLN2 PITPNM2 CACNB3 AMPH KALRN SYNE1 DGKZ SIK3 OPA1 MTOR MACF1 APPL1 | 2.17e-11 | 281 | 211 | 16 | 28706196 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CDK9 MYH10 SPTAN1 SRP68 UPF3A USP9Y EPB41L3 NUP205 CEP170 NEFL SUPT5H SUN2 SEC23B NPM1 CDC42BPA KALRN SYNE1 CECR2 MYO18A APC CHD7 SIK3 OPA1 IWS1 UPF2 MACF1 POLDIP2 TOP1 | 1.19e-10 | 1082 | 211 | 28 | 38697112 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZGRF1 ANKRD49 UBN2 BRCA2 ANAPC1 SUPT5H MED27 GOLGB1 CAPZA1 CAPZA2 APC CHD7 CEP192 ARFGEF3 SLF2 SASS6 MACF1 SPRTN PCM1 PCNT | 6.57e-10 | 588 | 211 | 20 | 38580884 |
| Pubmed | SMG1 MYH3 MYH10 CENPF SPTAN1 UGGT1 ACTN2 EPB41L3 LRRC43 NUP205 NEFL STARD9 KIF5A KIAA2012 DNAH8 GOLGB1 NPM1 PCDHGC5 SYNE1 PCDHGA1 CAPZA1 CAPZA2 NUMA1 MYO18A APOB SMC2 MACF1 CEP295 MYOM2 TOP1 PCNT | 1.03e-09 | 1442 | 211 | 31 | 35575683 | |
| Pubmed | HAUS3 TUBGCP4 CEP170 CEP78 CEP162 CEP192 SASS6 CEP295 CSPP1 PCM1 PCNT | 1.69e-09 | 146 | 211 | 11 | 21399614 | |
| Pubmed | MYH10 BCAS3 SPTAN1 SRP68 ACTN2 EPB41L3 SUCLG1 CEP170 NEFL LONP1 OSBPL8 TJP2 TLN2 NPM1 PITPNM2 AMPH KALRN SYNE1 CAPZA1 CAPZA2 MYO18A APC DGKZ OPA1 UPF2 MACF1 TOP1 PCM1 CACNA2D3 DNAH11 | 3.50e-09 | 1431 | 211 | 30 | 37142655 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.54e-09 | 120 | 211 | 10 | 31413325 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CENPF UGGT1 NUP205 CEP170 NEFL LONP1 FBXW8 SUPT5H TJP2 HERC2 GOLGB1 NPM1 IPO7 SYNE1 CAPZA1 CAPZA2 NUMA1 LAMB2 SMC2 FAM83H CNNM3 MACF1 TOP1 PCM1 PCNT | 4.11e-09 | 1024 | 211 | 25 | 24711643 |
| Pubmed | MYH10 BCAS3 SPTAN1 KCNB2 EPB41L3 SUCLG1 CEP170 LONP1 OSBPL8 TJP2 TLN2 NPM1 PITPNM2 CACNA1B AMPH CDC42BPA KALRN MYO18A APC OPA1 ARFGEF3 MACF1 APPL1 NDRG4 SNX1 PCM1 | 7.78e-09 | 1139 | 211 | 26 | 36417873 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYH10 BCAS3 OBSCN ADGRV1 UBN2 ITPK1 ZNF461 PCNX2 CEP170 TGFBRAP1 MED27 USP3 GOLGB1 PITPNM2 DDR1 CACNB3 B3GNTL1 CDC42BPA AFF3 CAPZA1 CEP192 RLF ARFGEF3 FAM13A DIP2C MACF1 ANKRD24 ARHGEF26 PCM1 PCNT | 8.63e-09 | 1489 | 211 | 30 | 28611215 |
| Pubmed | SMG1 ADGRV1 OSBPL8 TLN2 SYNE1 CHD7 SIK3 DIP2C MACF1 APPL1 NDRG4 PCNT | 1.53e-08 | 225 | 211 | 12 | 12168954 | |
| Pubmed | SPTAN1 ANKRD49 USP9Y NEFL SUPT5H OSBPL8 PDZD8 TLN2 KIF5A HERC2 USP13 KALRN SYNE1 CAPZA2 APC USP2 SLF2 ASCL1 MACF1 APPL1 ANKRD24 ANKRD36 POLDIP2 TOP1 SNX1 PCM1 PCNT | 2.19e-08 | 1285 | 211 | 27 | 35914814 | |
| Pubmed | CDK9 ERCC6 MCC TSPYL1 EPB41L3 SUCLG1 ZNF461 CEP170 ANAPC1 SUN2 NPM1 SEMG1 FOXP2 CECR2 SIK3 OPA1 TFDP2 FAM83H TRMT2A MACF1 CEP295 POLDIP2 DHX34 TOP1 PCM1 | 2.23e-08 | 1116 | 211 | 25 | 31753913 | |
| Pubmed | SPTAN1 SRP68 EPB41L3 CEP170 SUN2 OSBPL8 TJP2 NPM1 CAPZA1 TOP1 | 4.43e-08 | 156 | 211 | 10 | 29961565 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 CENPF SPTAN1 UGGT1 SRP68 EPB41L3 NUP205 LONP1 ANAPC1 SUPT5H STARD9 TLN2 DNAH5 NPM1 DNHD1 IPO7 SYNE1 CAPZA1 CAPZA2 NUMA1 APOB SMC2 OPA1 DARS2 TGM3 MTOR POLDIP2 TOP1 | 4.82e-08 | 1425 | 211 | 28 | 30948266 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH10 ZGRF1 SPTAN1 MCC HAUS3 CCDC144CP ZNF804A NEFL TLN2 KIF5A GOLGB1 NPM1 CAPZA1 CAPZA2 NUMA1 DGKZ SMC2 UPF2 MACF1 TOP1 PCNT | 6.00e-08 | 847 | 211 | 21 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYH10 HAUS3 NUP205 LONP1 BRCA2 TJP2 HERC2 GOLGA5 LCA5 CEP162 CAPZA1 APC CEP192 SIK3 SPAG5 FAM83H TGM3 SASS6 CEP295 PCM1 PCNT | 6.75e-08 | 853 | 211 | 21 | 28718761 |
| Pubmed | CDK18 SRP68 ADGRV1 NEFL STARD9 TJP2 HERC2 CHMP4C DDR1 CAPZA1 CAPZA2 MYO18A APC DGKZ MACF1 | 7.03e-08 | 430 | 211 | 15 | 32581705 | |
| Pubmed | SPTAN1 SRP68 HAUS3 EPB41L3 UBN2 CEP170 KIF5A MED27 USP3 CEP162 SPAG5 IWS1 RLF POLDIP2 CSPP1 SNX1 PCM1 PCNT | 9.82e-08 | 645 | 211 | 18 | 25281560 | |
| Pubmed | CDK18 SPTAN1 TSPYL1 EPB41L3 CEP170 LONP1 ANAPC1 TJP2 CEP162 APC CEP192 CEP295 CSPP1 PCM1 SAMD4A | 1.13e-07 | 446 | 211 | 15 | 24255178 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CDK9 SPTAN1 SRP68 TUBGCP4 EPB41L3 ITPK1 ANAPC1 TLN2 SEC23B GOLGB1 IPO7 CAPZA1 CHD7 SMC2 MACF1 TOP1 PCNT | 1.19e-07 | 582 | 211 | 17 | 20467437 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CDK9 UGGT1 SUCLG1 ANAPC1 SUPT5H SUN2 OSBPL8 PDZD8 DNHD1 CAPZA1 NUMA1 SMC2 USP2 TGM3 MTOR NOM1 CYB5R4 PCNT | 1.72e-07 | 670 | 211 | 18 | 22990118 |
| Pubmed | CDK9 TUBGCP4 NUP205 LONP1 SERPINB9 OSBPL8 PDZD8 KIF5A HERC2 GOLGA5 MUL1 GOLGB1 NPM1 IPO7 PIGK MYO18A OPA1 CNNM3 MTOR ARHGAP45 DHX34 CTSW PCM1 PCNT | 2.13e-07 | 1168 | 211 | 24 | 19946888 | |
| Pubmed | SMG1 MYH10 SPTAN1 UGGT1 DAB2 TUBGCP4 SUCLG1 UBN2 NUP205 CEP170 LONP1 SUN2 OSBPL8 TJP2 IPO7 PIGK CAPZA1 CAPZA2 NUMA1 SMC2 SPAG5 IWS1 ARFGEF3 MTOR NOM1 PCM1 SAMD4A | 2.17e-07 | 1440 | 211 | 27 | 30833792 | |
| Pubmed | MYH10 SPTAN1 UGGT1 SRP68 SUCLG1 ITIH2 NUP205 CEP170 CEP78 STARD9 OSBPL8 TJP2 HERC2 MED27 NPM1 CDC42BPA IPO7 PIGK CAPZA2 NUMA1 APOB CHD7 UPF2 NOM1 TOP1 PCM1 | 2.99e-07 | 1371 | 211 | 26 | 36244648 | |
| Pubmed | CENPF ZGRF1 EPB41L3 BRCA2 ANAPC1 GOLGA5 GOLGB1 APC CHD7 ZBTB1 SPAG5 RLF PCM1 PCNT | 3.17e-07 | 418 | 211 | 14 | 34709266 | |
| Pubmed | SRP68 EPB41L3 LRIG2 SYDE2 TJP2 GOLGA5 SEC23B GOLGB1 NPM1 CDC42BPA CEP162 APC APOB CEP192 ARFGEF3 CNNM3 NOM1 SNX1 PCM1 | 3.25e-07 | 777 | 211 | 19 | 35844135 | |
| Pubmed | MYH10 SPTAN1 DAB2 EPB41L3 KIF5A HERC2 GOLGB1 CDC42BPA SYNE1 MYO18A APC LAMB2 SIK3 MACF1 ANKRD24 | 3.37e-07 | 486 | 211 | 15 | 20936779 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.92e-07 | 197 | 211 | 10 | 20811636 | |
| Pubmed | 3.93e-07 | 151 | 211 | 9 | 17043677 | ||
| Pubmed | MYH10 UGGT1 DAB2 SRP68 FANCC CEP170 LONP1 FBXW8 SERPINB9 BRCA2 SUPT5H MYO18A TFDP2 SPAG5 NOM1 MACF1 PCM1 | 3.94e-07 | 634 | 211 | 17 | 34591612 | |
| Pubmed | CDK18 SPTAN1 UGGT1 EPB41L3 BCS1L LRIG2 SUN2 OSBPL8 PDZD8 HERC2 GOLGA5 GOLGB1 NPM1 CDC42BPA IPO7 SYNE1 MYO18A CEP192 SIK3 DARS2 CNNM3 MACF1 POLDIP2 CSPP1 SNX1 PCM1 PCNT | 4.06e-07 | 1487 | 211 | 27 | 33957083 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | SMG1 SPTAN1 UGGT1 HAUS3 TUBGCP4 ADGRG4 CEP170 LONP1 CEP78 HERC2 NPM1 APC CEP192 ZNF804B CCDC87 POLDIP2 PCM1 | 4.39e-07 | 639 | 211 | 17 | 23443559 |
| Pubmed | SMG1 MYH3 OBSCN SRP68 ACTN2 CEP170 CDC42BPA IPO7 KALRN SYNE1 CCDC141 UPF2 MACF1 APPL1 MYOM2 | 4.47e-07 | 497 | 211 | 15 | 23414517 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SMG1 MYH10 CENPF EPB41L3 CEP170 SUN2 OSBPL8 TLN2 NPM1 IPO7 NUMA1 SMC2 DARS2 MACF1 TOP1 | 4.58e-07 | 498 | 211 | 15 | 36634849 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH10 UGGT1 ANAPC1 HERC2 NPM1 CDC42BPA IPO7 NUMA1 MYO18A MTOR | 4.93e-07 | 202 | 211 | 10 | 33005030 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CDK9 MYH10 ERCC6 CENPF SPTAN1 UGGT1 SRP68 ITIH2 NUP205 CEP170 SUN2 TJP2 NPM1 IPO7 CAPZA1 CAPZA2 NUMA1 MYO18A SMC2 FAM83H TGM3 UPF2 NOM1 TOP1 | 7.87e-07 | 1257 | 211 | 24 | 36526897 |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 11544179 | ||
| Pubmed | TRIM75 NUP205 NEFL SUPT5H SUN2 IPO7 CECR2 NUMA1 CHD7 SMC2 CCDC141 IWS1 NOM1 POLDIP2 | 1.24e-06 | 469 | 211 | 14 | 27634302 | |
| Pubmed | SRP68 EPB41L3 CEP170 OSBPL8 PDZD8 GOLGB1 NPM1 CDC42BPA IPO7 CAPZA1 NUMA1 APC SMC2 OPA1 MACF1 ARHGEF26 TOP1 | 1.78e-06 | 708 | 211 | 17 | 39231216 | |
| Pubmed | BCAS3 PCNX2 STARD9 KIF5A GOLGA5 KALRN SYNE1 RGL3 CEP295 DNAH11 | 1.80e-06 | 233 | 211 | 10 | 37704626 | |
| Pubmed | MYH10 SPTAN1 SUCLG1 NPM1 IPO7 CAPZA1 CAPZA2 MYO18A APOB OPA1 | 1.80e-06 | 233 | 211 | 10 | 29518331 | |
| Pubmed | 2.34e-06 | 187 | 211 | 9 | 26460568 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | BCAS3 SPTAN1 SRP68 HAUS3 EPB41L3 UBN2 CEP170 CEP78 ANAPC1 TJP2 CAPZA1 MYO18A APC UPF2 NOM1 MACF1 TOP1 | 2.40e-06 | 724 | 211 | 17 | 36232890 |
| Pubmed | SMG1 TUBGCP4 CEP78 SUPT5H SEC23B USP13 PGS1 APC SIK3 SMC2 SPAG5 TRMT2A UPF2 NOM1 POLDIP2 DHX34 | 2.63e-06 | 650 | 211 | 16 | 38777146 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 2.91e-06 | 101 | 211 | 7 | 24613305 | |
| Pubmed | CDK9 MYH10 SPTAN1 UGGT1 NUP205 SUPT5H NPM1 CAPZA1 CAPZA2 NUMA1 MYO18A IWS1 MACF1 SERPINC1 TOP1 PCM1 | 3.20e-06 | 660 | 211 | 16 | 32780723 | |
| Pubmed | FBXW12 UGGT1 OBSCN ANKRD49 UBN2 DCAF17 TJP2 USP3 GOLGB1 CEP162 CAPZA2 APC MPEG1 DGKZ APOB CHD7 CEP192 SPAG5 MACF1 CEP295 PCNT | 3.21e-06 | 1084 | 211 | 21 | 11544199 | |
| Pubmed | SPTAN1 EPB41L3 NEFL TLN2 KALRN SYNE1 CAPZA2 DGKZ MACF1 ADGRA1 | 3.50e-06 | 251 | 211 | 10 | 27507650 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KLHL24 MYH10 MYO10 SRP68 NUP205 LONP1 SUN2 TJP2 HERC2 USP3 USP13 IPO7 CAPZA1 APC CEP192 IWS1 USP2 TGM3 TRMT2A SASS6 | 3.74e-06 | 1005 | 211 | 20 | 19615732 |
| Pubmed | 3.77e-06 | 18 | 211 | 4 | 25220460 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CENPF UGGT1 CEP170 SUN2 HERC2 GOLGB1 USP13 IPO7 ZNRD2 PIGK MYO18A SIK3 TRMT2A MTOR POLDIP2 PCM1 PCNT | 4.11e-06 | 754 | 211 | 17 | 33060197 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.17e-06 | 256 | 211 | 10 | 33397691 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CDK9 PCNX3 MYO10 BCAS3 OBSCN PCNX2 PDZD8 TLN2 HERC2 PITPNM2 CDC42BPA KALRN LAMB2 CEP192 FAM83H KLHL25 MEGF8 MTOR DIP2C DHX34 PCNT | 4.31e-06 | 1105 | 211 | 21 | 35748872 |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 33347437 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 12554878 | ||
| Pubmed | MYH3 SPTAN1 UGGT1 PCDHB5 SUCLG1 BCS1L CEP170 SUPT5H MED27 SEC23B GOLGB1 CA1 NPM1 SEMG1 LILRA2 ZNRD2 APC LAMB2 MTOR SRGN MYOM2 PCM1 PCNT | 4.40e-06 | 1293 | 211 | 23 | 15342556 | |
| Pubmed | 4.75e-06 | 19 | 211 | 4 | 24421332 | ||
| Pubmed | UGGT1 SUCLG1 BCS1L CEP170 BRCA2 ANAPC1 SUN2 HERC2 PIGK OPA1 DARS2 FAM83H TRMT2A MTOR NOM1 | 5.10e-06 | 606 | 211 | 15 | 36538041 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CDK9 MYH10 SPTAN1 UGGT1 SRP68 CEP170 LONP1 OSBPL8 SEC23B GOLGB1 NPM1 IPO7 CAPZA1 CAPZA2 NUMA1 SMC2 OPA1 DARS2 SPAG5 IWS1 MACF1 POLDIP2 TOP1 SNX1 | 6.00e-06 | 1415 | 211 | 24 | 28515276 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | MYO10 BCAS3 DAB2 SRP68 HAUS3 UPF3A CEP170 FBXW8 CEP78 TJP2 SEC23B CHMP4C PITPNM2 DGKZ ZBTB1 IWS1 UPF2 MTOR PDE8B SAMD4A | 6.03e-06 | 1038 | 211 | 20 | 26673895 |
| Pubmed | 6.03e-06 | 210 | 211 | 9 | 16565220 | ||
| Pubmed | KLHL24 CENPF MYO10 SPTAN1 DNAH5 NUMA1 LRRTM2 MACF1 SPRTN ALPK2 PCM1 | 6.63e-06 | 332 | 211 | 11 | 37433992 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH10 SPTAN1 EPB41L3 SUCLG1 NEFL BRCA2 AMPH IPO7 FOXP2 CAPZA1 CAPZA2 MYO18A SMC2 OPA1 MTOR | 6.83e-06 | 621 | 211 | 15 | 22794259 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | SMG1 MYH10 SPTAN1 CEP170 TJP2 HERC2 NPM1 CAPZA1 CAPZA2 NUMA1 MYO18A CHD7 OPA1 TOP1 PCM1 | 7.51e-06 | 626 | 211 | 15 | 33644029 |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 14636577 | ||
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 9256245 | ||
| Pubmed | Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. | 7.57e-06 | 7 | 211 | 3 | 17916692 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 31178125 | ||
| Pubmed | MYH10 SPTAN1 UGGT1 EPB41L3 CEP170 TJP2 SEC23B CDC42BPA MYO18A TOP1 | 7.57e-06 | 274 | 211 | 10 | 34244482 | |
| Pubmed | ITPK1 NEFL SERPINB9 TJP2 TLN2 IPO7 CAPZA1 LAMB2 MACF1 APPL1 NDRG4 | 8.52e-06 | 341 | 211 | 11 | 29791485 | |
| Pubmed | 8.84e-06 | 22 | 211 | 4 | 12812986 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 ERCC6 SPTAN1 SRP68 EPB41L3 NUP205 LONP1 HERC2 USP3 NPM1 IPO7 CAPZA1 CAPZA2 NUMA1 CHD7 SMC2 FAM83H RLF TGM3 UPF2 MACF1 DHX34 TOP1 | 9.16e-06 | 1353 | 211 | 23 | 29467282 |
| Pubmed | UGGT1 TSPYL1 TUBGCP4 BCS1L CEP170 LONP1 ANAPC1 SUPT5H OSBPL8 IPO7 NUMA1 SMC2 OPA1 TRMT2A | 9.48e-06 | 560 | 211 | 14 | 35241646 | |
| Pubmed | 9.73e-06 | 282 | 211 | 10 | 23667531 | ||
| Pubmed | 1.09e-05 | 48 | 211 | 5 | 27872092 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CDK9 SMG1 MYH3 CEP170 ANAPC1 OSBPL8 CNN1 DDR1 CDC42BPA AFF3 CEP192 SIK3 DARS2 TFDP2 FAM83H TGM3 TRMT2A ANKRD36 | 1.27e-05 | 910 | 211 | 18 | 36736316 |
| Pubmed | CDK9 UGGT1 EPB41L3 NUP205 CEP170 NEFL LONP1 SYDE2 TJP2 CDC42BPA ZNRD2 CAPZA2 NUMA1 TGM3 FAM13A APPL1 POLDIP2 ARHGEF26 | 1.38e-05 | 916 | 211 | 18 | 32203420 | |
| Pubmed | 1.44e-05 | 234 | 211 | 9 | 36243803 | ||
| Pubmed | 1.51e-05 | 25 | 211 | 4 | 38877142 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.56e-05 | 87 | 211 | 6 | 17148452 | |
| Pubmed | 1.62e-05 | 131 | 211 | 7 | 28634551 | ||
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 1.77e-05 | 26 | 211 | 4 | 14654843 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC6 CENPF SRP68 TSPYL1 NUP205 CEP170 CEP78 HERC2 NPM1 NUMA1 MYO18A SMC2 UPF2 NOM1 MACF1 TOP1 | 1.81e-05 | 759 | 211 | 16 | 35915203 |
| Pubmed | 1.86e-05 | 304 | 211 | 10 | 32235678 | ||
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 1.94e-05 | 243 | 211 | 9 | 36964488 | |
| Pubmed | 2.15e-05 | 92 | 211 | 6 | 37343697 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 MYO10 SPTAN1 DAB2 SRP68 NPM1 IPO7 SYNE1 CAPZA1 CAPZA2 NUMA1 MYO18A LAMB2 APOB TGM3 TRMT2A NOM1 TOP1 | 2.20e-05 | 949 | 211 | 18 | 36574265 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | CDK9 EPB41L3 CEP78 HERC2 ZNRD2 NUMA1 LAMB2 SMC2 ARFGEF3 POLDIP2 | 2.39e-05 | 313 | 211 | 10 | 38270169 |
| Pubmed | MYH10 SPTAN1 UGGT1 NEFL LONP1 SUPT5H SUN2 PDZD8 HERC2 GOLGA5 CDC42BPA IPO7 CEP162 CEP192 OPA1 IWS1 CNNM3 CSPP1 PCNT | 2.44e-05 | 1049 | 211 | 19 | 27880917 | |
| Pubmed | MYH10 SPTAN1 EPB41L3 NUP205 CEP170 SUN2 HERC2 NPM1 IPO7 SMC2 NOM1 | 2.50e-05 | 383 | 211 | 11 | 29331416 | |
| Pubmed | Cell polarity and spindle orientation in the distal epithelium of embryonic lung. | 2.56e-05 | 10 | 211 | 3 | 21246661 | |
| Pubmed | CDK9 MYH10 SPTAN1 SRP68 UPF3A TUBGCP4 SUCLG1 LONP1 SUN2 MED27 NPM1 CDC42BPA IPO7 CAPZA1 CAPZA2 NUMA1 APC SMC2 OPA1 FAM83H TOP1 | 2.63e-05 | 1247 | 211 | 21 | 27684187 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 2.77e-05 | 58 | 211 | 5 | 12852856 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CENPF MCC HAUS3 TUBGCP4 FANCC CEP170 CEP78 ANAPC1 TLN2 HERC2 SYNE1 CAPZA1 NUMA1 APC CEP170P1 CEP192 SPAG5 FAM83H SASS6 PCM1 | 2.80e-05 | 1155 | 211 | 20 | 20360068 |
| Pubmed | MYH10 MYO10 SPTAN1 NEFL NPM1 CDC42BPA CAPZA1 NUMA1 SMC2 UPF2 MTOR MACF1 TOP1 | 2.82e-05 | 538 | 211 | 13 | 28524877 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CDK9 CENPF SUCLG1 NUP205 DNAH5 DNAH8 SEC23B PIGK CAPZA2 NUMA1 SMC2 DARS2 UPF2 MTOR TOP1 | 2.95e-05 | 704 | 211 | 15 | 29955894 |
| Interaction | DISC1 interactions | SPTAN1 SRP68 HAUS3 ACTN2 EPB41L3 CEP170 SUN2 OSBPL8 TJP2 HERC2 NPM1 KALRN SYNE1 CAPZA1 SMC2 CCDC141 SPAG5 FAM83H CRYBA4 USP2 MACF1 TOP1 PCM1 PCNT | 2.32e-11 | 429 | 210 | 24 | int:DISC1 |
| Interaction | NIN interactions | HAUS3 NUP205 CEP170 LONP1 BRCA2 HERC2 LCA5 CEP162 CAPZA1 APC CEP170P1 CEP192 SPAG5 FAM83H ARFGEF3 SASS6 CEP295 CSPP1 PCM1 PCNT | 1.27e-09 | 359 | 210 | 20 | int:NIN |
| Interaction | SIRT7 interactions | CDK9 MYH10 CENPF SPTAN1 UGGT1 SRP68 EPB41L3 NUP205 CEP170 NEFL LONP1 ANAPC1 SUPT5H OSBPL8 TJP2 HERC2 SEC23B NPM1 IPO7 NUMA1 CHD7 TGM3 MTOR MACF1 TOP1 PCM1 PCNT | 1.75e-08 | 744 | 210 | 27 | int:SIRT7 |
| Interaction | CEP162 interactions | HAUS3 CEP170 LONP1 HERC2 CHMP4C LCA5 IPO7 CEP162 MYO18A SASS6 CSPP1 PCM1 PCNT | 2.42e-08 | 168 | 210 | 13 | int:CEP162 |
| Interaction | RPGRIP1L interactions | HAUS3 CEP170 LONP1 LCA5 IPO7 CEP162 CAPZA1 CAPZA2 APC CEP192 SPAG5 CSPP1 PCM1 PCNT | 1.08e-07 | 225 | 210 | 14 | int:RPGRIP1L |
| Interaction | CEP135 interactions | HAUS3 CEP170 BRCA2 TJP2 HERC2 GOLGB1 CEP162 APC CEP192 FAM83H SASS6 CEP295 CSPP1 PCM1 PCNT | 1.82e-07 | 272 | 210 | 15 | int:CEP135 |
| Interaction | MAPRE1 interactions | ERCC6 MYO10 SPTAN1 DAB2 SRP68 NUP205 CEP170 HERC2 LCA5 CEP162 CAPZA1 CAPZA2 NUMA1 APC SPAG5 FAM83H MACF1 CSPP1 PCM1 PCNT | 4.77e-07 | 514 | 210 | 20 | int:MAPRE1 |
| Interaction | YWHAZ interactions | CDK18 MYH10 SPTAN1 MCC EPB41L3 CEP170 NEFL STARD9 SYDE2 OSBPL8 TJP2 KIF5A HERC2 CHMP4C NPM1 LCA5 CDC42BPA IPO7 CEP162 CAPZA2 MYO18A APC CEP192 SIK3 SMC2 SPAG5 FAM83H FAM13A MTOR MACF1 APPL1 PCM1 SAMD4A PCNT | 8.66e-07 | 1319 | 210 | 34 | int:YWHAZ |
| Interaction | YWHAH interactions | CDK9 CDK18 BCAS3 SPTAN1 EPB41L3 CEP170 STARD9 SYDE2 OSBPL8 TJP2 KIF5A SEC23B LCA5 CDC42BPA CEP162 APC CEP192 SIK3 FAM83H ARFGEF3 FAM13A MEGF8 SLF2 MTOR MACF1 APPL1 CSPP1 PCM1 SAMD4A PCNT | 1.38e-06 | 1102 | 210 | 30 | int:YWHAH |
| Interaction | CEP120 interactions | 1.67e-06 | 106 | 210 | 9 | int:CEP120 | |
| Interaction | KRT18 interactions | CDK9 MCC HAUS3 TUBGCP4 NUP205 NEFL LONP1 NPM1 CDC42BPA CEP162 APC CEP192 SPAG5 FAM83H UPF2 CSPP1 PCNT | 2.04e-06 | 419 | 210 | 17 | int:KRT18 |
| Interaction | CEP63 interactions | SPTAN1 HAUS3 NPM1 SYNE1 CEP192 USP2 SASS6 MACF1 CSPP1 PCM1 PCNT | 2.91e-06 | 179 | 210 | 11 | int:CEP63 |
| Interaction | FMR1 interactions | SMG1 MCC CEP170 NEFL ANAPC1 KIF5A HERC2 NPM1 ZNRD2 CECR2 NUMA1 APC CHD7 SIK3 ZBTB1 SPAG5 MACF1 PCM1 PCNT | 3.67e-06 | 536 | 210 | 19 | int:FMR1 |
| Interaction | PLK4 interactions | CDC42BPA CAPZA2 APC CEP192 SMC2 SPAG5 FAM83H SASS6 CSPP1 PCNT | 5.08e-06 | 154 | 210 | 10 | int:PLK4 |
| Interaction | YWHAG interactions | CDK9 CDK18 MYH10 BCAS3 SPTAN1 MCC EPB41L3 CEP170 NEFL CEP78 STARD9 SYDE2 OSBPL8 TJP2 KIF5A SEC23B CHMP4C LCA5 CDC42BPA CEP162 APC CEP192 SIK3 FAM83H FAM13A MTOR MACF1 APPL1 CSPP1 PCM1 SAMD4A | 5.97e-06 | 1248 | 210 | 31 | int:YWHAG |
| Interaction | LUZP1 interactions | MCC HAUS3 CEP170 FBXW8 TJP2 CHMP4C LCA5 CEP162 CAPZA2 MYO18A PCM1 | 6.31e-06 | 194 | 210 | 11 | int:LUZP1 |
| Interaction | LCA5 interactions | 6.57e-06 | 125 | 210 | 9 | int:LCA5 | |
| Interaction | SASS6 interactions | 6.74e-06 | 159 | 210 | 10 | int:SASS6 | |
| Interaction | CSPP1 interactions | 7.35e-06 | 96 | 210 | 8 | int:CSPP1 | |
| Interaction | CHMP4B interactions | MYH10 SPTAN1 UGGT1 ACTN2 SUCLG1 CEP170 NEFL LONP1 BRCA2 OSBPL8 TJP2 TLN2 HERC2 GOLGB1 CHMP4C NPM1 IPO7 CAPZA1 CAPZA2 NUMA1 FAM83H TOP1 | 7.83e-06 | 727 | 210 | 22 | int:CHMP4B |
| Interaction | CCDC14 interactions | 8.49e-06 | 129 | 210 | 9 | int:CCDC14 | |
| Interaction | PCNT interactions | SPTAN1 IPO7 KALRN CEP162 SYNE1 CEP192 SASS6 MACF1 ANKRD24 CSPP1 PCM1 PCNT | 9.01e-06 | 241 | 210 | 12 | int:PCNT |
| Interaction | SNAPIN interactions | SMG1 MYH3 ACTN2 CEP170 HERC2 DDR1 CDC42BPA CEP170P1 SPAG5 MACF1 | 1.15e-05 | 169 | 210 | 10 | int:SNAPIN |
| Interaction | AGAP2 interactions | SPTAN1 MCC EPB41L3 NEFL TLN2 CACNB3 KALRN SYNE1 SIK3 MACF1 APPL1 | 1.33e-05 | 210 | 210 | 11 | int:AGAP2 |
| Interaction | TERF2 interactions | CDK9 MYH10 CENPF MYO10 BRCA2 SUPT5H SYNE1 NUMA1 CHD7 DARS2 MACF1 MYOM2 TOP1 PCM1 | 1.41e-05 | 340 | 210 | 14 | int:TERF2 |
| Interaction | KIF20A interactions | MYH10 TRIM75 SPTAN1 ACTN2 TSPYL1 USP9Y NUP205 PCNX2 CEP170 NEFL LONP1 TJP2 PDZD8 HERC2 NPM1 ZNRD2 PIGK SYNE1 CAPZA1 CAPZA2 NUMA1 MYO18A APOB FAM83H MACF1 TOP1 PCM1 | 1.43e-05 | 1052 | 210 | 27 | int:KIF20A |
| Interaction | PMS1 interactions | 1.43e-05 | 105 | 210 | 8 | int:PMS1 | |
| Interaction | OFD1 interactions | BCAS3 HAUS3 CEP170 LONP1 SUPT5H LCA5 CEP162 CEP192 SPAG5 SASS6 CEP295 CSPP1 PCM1 PCNT | 1.77e-05 | 347 | 210 | 14 | int:OFD1 |
| Interaction | RCOR1 interactions | MYH10 CENPF ZGRF1 SPTAN1 EPB41L3 BRCA2 ANAPC1 GOLGA5 NPM1 NUMA1 APC LAMB2 CHD7 SMC2 ZBTB1 RLF PCM1 | 1.78e-05 | 494 | 210 | 17 | int:RCOR1 |
| Interaction | SYNE3 interactions | UGGT1 LONP1 BRCA2 ANAPC1 SUN2 OSBPL8 PDZD8 PIGK APC CEP192 SPAG5 FAM83H MACF1 CEP295 CSPP1 PCNT | 1.80e-05 | 444 | 210 | 16 | int:SYNE3 |
| Interaction | YWHAE interactions | CDK18 MYH10 SPTAN1 MCC EPB41L3 CEP170 SYDE2 OSBPL8 TJP2 KIF5A SEC23B CHMP4C NPM1 LCA5 CDC42BPA CAPZA1 CAPZA2 APC SIK3 SMC2 TFDP2 FAM83H FAM13A MTOR MACF1 APPL1 SPRTN ARHGAP45 PCM1 SAMD4A | 1.82e-05 | 1256 | 210 | 30 | int:YWHAE |
| Interaction | CCDC8 interactions | UGGT1 NUP205 CEP170 NEFL FBXW8 HERC2 GOLGB1 NPM1 IPO7 AFF3 CAPZA2 NUMA1 LAMB2 APOB SMC2 FAM83H CNNM3 MACF1 PCM1 PCNT | 1.86e-05 | 656 | 210 | 20 | int:CCDC8 |
| Interaction | CEP152 interactions | HAUS3 EPB41L3 NPM1 CEP192 SMC2 ARFGEF3 SASS6 CEP295 PCM1 PCNT | 1.90e-05 | 179 | 210 | 10 | int:CEP152 |
| Interaction | CEP290 interactions | 1.90e-05 | 179 | 210 | 10 | int:CEP290 | |
| Interaction | CLEC4D interactions | MYH10 SPTAN1 ACTN2 LRIG2 LONP1 OSBPL8 PDZD8 SEC23B GOLGB1 CAPZA2 MYO18A OPA1 | 2.00e-05 | 261 | 210 | 12 | int:CLEC4D |
| Interaction | YWHAB interactions | CDK18 SPTAN1 MCC EPB41L3 CEP170 STARD9 SYDE2 SUN2 TJP2 KIF5A SEC23B CHMP4C LCA5 CDC42BPA CEP162 CAPZA1 APC CEP192 SIK3 FAM83H FAM13A MTOR MACF1 APPL1 PCM1 SAMD4A | 2.12e-05 | 1014 | 210 | 26 | int:YWHAB |
| Interaction | MED4 interactions | SPTAN1 SRP68 HAUS3 EPB41L3 CEP170 KIF5A HERC2 MED27 LCA5 CEP162 SPAG5 SASS6 CSPP1 SNX1 PCM1 PCNT | 2.13e-05 | 450 | 210 | 16 | int:MED4 |
| Interaction | NINL interactions | TUBGCP4 CEP170 BRCA2 LCA5 CEP162 CAPZA1 CAPZA2 CEP192 SMC2 SPAG5 FAM83H SASS6 CEP295 CSPP1 PCM1 PCNT | 2.63e-05 | 458 | 210 | 16 | int:NINL |
| Interaction | CDK9 interactions | CDK9 MYH10 MYO10 SPTAN1 SRP68 NUP205 BRCA2 SUPT5H NPM1 CDC42BPA AFF3 CAPZA1 CAPZA2 NUMA1 MYO18A APC SMC2 OPA1 CCDC87 TOP1 | 3.43e-05 | 685 | 210 | 20 | int:CDK9 |
| Interaction | CNTRL interactions | HAUS3 NUP205 CEP170 LONP1 TJP2 CEP162 CEP192 CSPP1 PCM1 PCNT | 3.63e-05 | 193 | 210 | 10 | int:CNTRL |
| Interaction | ACTR2 interactions | ERCC6 MYO10 DAB2 CEP170 SYDE2 CHMP4C CAPZA1 CAPZA2 MYO18A UPF2 APPL1 SPRTN PCM1 | 3.64e-05 | 323 | 210 | 13 | int:ACTR2 |
| Interaction | KIAA0753 interactions | 4.08e-05 | 157 | 210 | 9 | int:KIAA0753 | |
| Interaction | YWHAQ interactions | CDK18 ACTN2 EPB41L3 CEP170 FBXW8 STARD9 SYDE2 TJP2 KIF5A SEC23B GOLGB1 CHMP4C NPM1 LCA5 CDC42BPA CEP162 NUMA1 APC CEP192 SIK3 FAM83H FAM13A MTOR MACF1 APPL1 PCM1 SAMD4A | 4.13e-05 | 1118 | 210 | 27 | int:YWHAQ |
| Interaction | TMOD1 interactions | 4.97e-05 | 161 | 210 | 9 | int:TMOD1 | |
| Interaction | KCTD13 interactions | MYH10 BCAS3 SPTAN1 SRP68 ACTN2 EPB41L3 SUCLG1 CEP170 NEFL LONP1 OSBPL8 TJP2 TLN2 NPM1 PITPNM2 AMPH KALRN SYNE1 CAPZA1 CAPZA2 MYO18A APC DGKZ OPA1 UPF2 MACF1 SPRTN TOP1 PCM1 CACNA2D3 DNAH11 | 5.11e-05 | 1394 | 210 | 31 | int:KCTD13 |
| Interaction | WDR76 interactions | MYH10 SPTAN1 MCC IKZF1 LONP1 ANAPC1 SUPT5H ZNRD2 CAPZA2 NUMA1 LAMB2 CHD7 IWS1 TOP1 | 5.22e-05 | 383 | 210 | 14 | int:WDR76 |
| Interaction | PCM1 interactions | HAUS3 TSPYL1 CEP170 SUPT5H HERC2 LCA5 CEP162 CEP170P1 CEP192 SPAG5 SASS6 CEP295 CSPP1 PCM1 PCNT | 5.33e-05 | 434 | 210 | 15 | int:PCM1 |
| Interaction | SLC6A4 interactions | CDK18 SRP68 ADGRV1 NEFL STARD9 TJP2 HERC2 CHMP4C DDR1 CAPZA1 CAPZA2 MYO18A APC DGKZ MACF1 | 5.76e-05 | 437 | 210 | 15 | int:SLC6A4 |
| Interaction | LRRC31 interactions | MYH10 UGGT1 ANAPC1 HERC2 NPM1 CDC42BPA IPO7 NUMA1 MYO18A MTOR | 6.04e-05 | 205 | 210 | 10 | int:LRRC31 |
| Interaction | PHF21A interactions | CENPF ZGRF1 BRCA2 ANAPC1 GOLGA5 GOLGB1 APC CHD7 ZBTB1 SPAG5 RLF PCM1 PCNT | 6.73e-05 | 343 | 210 | 13 | int:PHF21A |
| Interaction | SHANK3 interactions | SPTAN1 ACTN2 EPB41L3 NEFL TLN2 KIF5A NPM1 AMPH KALRN SYNE1 CAPZA2 NUMA1 SPAG5 ARFGEF3 FAM13A MACF1 | 6.80e-05 | 496 | 210 | 16 | int:SHANK3 |
| Interaction | MECP2 interactions | CDK9 MYH10 SPTAN1 SRP68 UPF3A USP9Y EPB41L3 NUP205 CEP170 NEFL SUPT5H SUN2 SEC23B NPM1 CDC42BPA KALRN SYNE1 CECR2 MYO18A APC CHD7 SIK3 OPA1 IWS1 UPF2 MACF1 POLDIP2 TOP1 SNX1 | 7.27e-05 | 1287 | 210 | 29 | int:MECP2 |
| Interaction | GAN interactions | SPTAN1 NEFL DNAH8 NPM1 DNHD1 SYNE1 MYO18A ANKRD36 CSPP1 SAMD4A PCNT | 7.35e-05 | 253 | 210 | 11 | int:GAN |
| Interaction | ITGB3 interactions | 7.57e-05 | 170 | 210 | 9 | int:ITGB3 | |
| Interaction | FBF1 interactions | 7.92e-05 | 171 | 210 | 9 | int:FBF1 | |
| Interaction | BRCA1 interactions | CDK9 MYH10 ERCC6 CENPF SPTAN1 UGGT1 OBSCN SRP68 FANCC CEP170 SERPINB9 BRCA2 SUPT5H HERC2 GOLGA5 SEC23B NPM1 DNHD1 IPO7 CAPZA1 NUMA1 ZBTB1 SPAG5 FAM83H USP2 SLF2 MTOR TOP1 | 1.07e-04 | 1249 | 210 | 28 | int:BRCA1 |
| Interaction | NDC80 interactions | CDK9 HAUS3 HERC2 CEP162 CEP192 OPA1 SPAG5 CEP295 CSPP1 TOP1 PCM1 PCNT | 1.12e-04 | 312 | 210 | 12 | int:NDC80 |
| Interaction | KCNA3 interactions | SRP68 EPB41L3 CEP170 OSBPL8 PDZD8 TLN2 DNAH5 GOLGB1 NPM1 DNHD1 CACNA1B CDC42BPA IPO7 CAPZA1 NUMA1 MYO18A APC SMC2 OPA1 MACF1 ARHGEF26 TOP1 | 1.18e-04 | 871 | 210 | 22 | int:KCNA3 |
| Interaction | CPAP interactions | 1.27e-04 | 182 | 210 | 9 | int:CPAP | |
| Interaction | GOLGA1 interactions | 1.33e-04 | 183 | 210 | 9 | int:GOLGA1 | |
| Interaction | SEPTIN10 interactions | 1.36e-04 | 144 | 210 | 8 | int:SEPTIN10 | |
| Interaction | UPF3A interactions | 1.39e-04 | 48 | 210 | 5 | int:UPF3A | |
| Interaction | DEUP1 interactions | 1.53e-04 | 77 | 210 | 6 | int:DEUP1 | |
| Interaction | SVIL interactions | PCNX3 CENPF SPTAN1 STARD9 TJP2 CHMP4C CAPZA1 CAPZA2 MYO18A TMEM132D | 1.74e-04 | 233 | 210 | 10 | int:SVIL |
| Interaction | CEP43 interactions | 1.76e-04 | 190 | 210 | 9 | int:CEP43 | |
| Interaction | CAPZA2 interactions | CDK9 MYH10 SPTAN1 DAB2 CALHM4 IPO7 CAPZA1 CAPZA2 NUMA1 MYO18A SMC2 TGM3 MACF1 CSPP1 | 1.77e-04 | 430 | 210 | 14 | int:CAPZA2 |
| Interaction | TNIK interactions | CENPF SPTAN1 UBN2 CEP170 LONP1 KIF5A HERC2 FOXP2 KALRN SYNE1 APC MACF1 PCM1 | 1.91e-04 | 381 | 210 | 13 | int:TNIK |
| Interaction | OBSL1 interactions | CENPF NUP205 NEFL FBXW8 MYLK3 SUPT5H CROCC2 TJP2 HERC2 GOLGB1 NPM1 CACNA1B SYNE1 CECR2 CAPZA1 CAPZA2 NUMA1 MACF1 TOP1 ALPK2 PCM1 PCNT | 1.94e-04 | 902 | 210 | 22 | int:OBSL1 |
| Interaction | DUSP16 interactions | HAUS3 BRCA2 ANAPC1 CEP192 SIK3 SPAG5 FAM83H CEP295 PCM1 PCNT | 1.99e-04 | 237 | 210 | 10 | int:DUSP16 |
| Interaction | SNAI1 interactions | MYH10 SPTAN1 ODAD4 ACTN2 EPB41L3 NUP205 CEP170 SUN2 HERC2 USP3 NPM1 USP13 IPO7 SMC2 USP2 NOM1 | 2.05e-04 | 546 | 210 | 16 | int:SNAI1 |
| Interaction | PHLPP1 interactions | CENPF SPTAN1 DAB2 SRP68 CEP170 GOLGB1 IPO7 APC SPAG5 SNX1 RFPL2 PCM1 | 2.05e-04 | 333 | 210 | 12 | int:PHLPP1 |
| Interaction | KIAA1671 interactions | 2.06e-04 | 194 | 210 | 9 | int:KIAA1671 | |
| Interaction | MAP7 interactions | 2.13e-04 | 239 | 210 | 10 | int:MAP7 | |
| Interaction | RGS14 interactions | MYH10 SPTAN1 SUCLG1 NPM1 IPO7 CAPZA1 CAPZA2 MYO18A APOB OPA1 | 2.21e-04 | 240 | 210 | 10 | int:RGS14 |
| Interaction | KRT8 interactions | CDK9 SMG1 HAUS3 NUP205 NEFL CEP162 CAPZA2 APC CEP192 SPAG5 FAM83H ZNF804B CSPP1 PCNT | 2.29e-04 | 441 | 210 | 14 | int:KRT8 |
| Interaction | SSX2IP interactions | HAUS3 ACTN2 HERC2 LCA5 IPO7 CEP162 NUMA1 SASS6 CSPP1 PCM1 PCNT | 2.29e-04 | 288 | 210 | 11 | int:SSX2IP |
| Interaction | WHAMMP3 interactions | 2.52e-04 | 119 | 210 | 7 | int:WHAMMP3 | |
| Interaction | CEP131 interactions | 2.58e-04 | 200 | 210 | 9 | int:CEP131 | |
| Interaction | FXR1 interactions | SMG1 CDK18 MYH10 ERCC6 CENPF ACTN2 EPB41L3 CEP170 NEFL IMMP1L HERC2 GOLGB1 CHMP4C NPM1 CECR2 CEP170P1 UPF2 PCM1 | 2.82e-04 | 679 | 210 | 18 | int:FXR1 |
| Interaction | KRT23 interactions | 2.89e-04 | 31 | 210 | 4 | int:KRT23 | |
| Interaction | HAUS6 interactions | 2.92e-04 | 161 | 210 | 8 | int:HAUS6 | |
| Interaction | CFAP184 interactions | 3.05e-04 | 162 | 210 | 8 | int:CFAP184 | |
| Interaction | DTNBP1 interactions | 3.05e-04 | 162 | 210 | 8 | int:DTNBP1 | |
| Interaction | NAP1L4 interactions | 3.21e-04 | 206 | 210 | 9 | int:NAP1L4 | |
| Interaction | CFAP96 interactions | 3.22e-04 | 3 | 210 | 2 | int:CFAP96 | |
| Interaction | RBM44 interactions | 3.22e-04 | 3 | 210 | 2 | int:RBM44 | |
| Interaction | NDEL1 interactions | 3.31e-04 | 164 | 210 | 8 | int:NDEL1 | |
| Interaction | CEP104 interactions | 3.37e-04 | 89 | 210 | 6 | int:CEP104 | |
| Interaction | DAPK3 interactions | 3.37e-04 | 89 | 210 | 6 | int:DAPK3 | |
| Interaction | OTUD7A interactions | 3.43e-04 | 58 | 210 | 5 | int:OTUD7A | |
| Interaction | CLEC4E interactions | MYH10 SPTAN1 LRIG2 LONP1 OSBPL8 PDZD8 SEC23B GOLGB1 CAPZA2 MYO18A OPA1 CNNM3 | 3.48e-04 | 353 | 210 | 12 | int:CLEC4E |
| Interaction | MYO18A interactions | CDK9 SPTAN1 DAB2 OPTC TJP2 CHMP4C CDC42BPA CEP162 CAPZA1 CAPZA2 MYO18A | 3.53e-04 | 303 | 210 | 11 | int:MYO18A |
| Interaction | H2BC21 interactions | CDK9 CENPF OBSCN ACTN2 EPB41L3 LONP1 CEP78 ANAPC1 SUPT5H MED27 DNAH5 NPM1 NUMA1 CHD7 SMC2 IWS1 RLF TOP1 | 3.79e-04 | 696 | 210 | 18 | int:H2BC21 |
| Interaction | FBXW7 interactions | CDK18 MYH10 BCAS3 HAUS3 SUCLG1 FANCC CEP170 LONP1 CEP78 TJP2 HERC2 MED27 NPM1 IPO7 FOXP2 NUMA1 MYO18A OPA1 CREB3L1 USP2 TGM3 MTOR NOM1 SASS6 MACF1 TOP1 | 3.93e-04 | 1215 | 210 | 26 | int:FBXW7 |
| Interaction | ECT2 interactions | MYH10 TRIM75 SPTAN1 SRP68 ACTN2 USP9Y SUCLG1 CEP170 NEFL TJP2 NPM1 IPO7 CAPZA1 CAPZA2 NUMA1 MYO18A PABPC4L TFDP2 FAM83H MACF1 TOP1 | 4.04e-04 | 887 | 210 | 21 | int:ECT2 |
| Interaction | FBXO42 interactions | ANAPC1 GOLGB1 CAPZA2 APC CHD7 CEP192 ARFGEF3 MACF1 PCM1 PCNT | 4.04e-04 | 259 | 210 | 10 | int:FBXO42 |
| Interaction | CACNA1C interactions | 4.34e-04 | 61 | 210 | 5 | int:CACNA1C | |
| Interaction | ACTN2 interactions | 4.38e-04 | 171 | 210 | 8 | int:ACTN2 | |
| Interaction | TCHP interactions | 4.53e-04 | 131 | 210 | 7 | int:TCHP | |
| Interaction | KNSTRN interactions | 4.53e-04 | 94 | 210 | 6 | int:KNSTRN | |
| GeneFamily | Dyneins, axonemal | 2.29e-04 | 17 | 130 | 3 | 536 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.37e-04 | 181 | 130 | 7 | 694 | |
| GeneFamily | Ubiquitin specific peptidases | 7.02e-04 | 56 | 130 | 4 | 366 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.37e-04 | 26 | 130 | 3 | 253 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-03 | 161 | 130 | 6 | 593 | |
| GeneFamily | Serpin peptidase inhibitors | 2.36e-03 | 37 | 130 | 3 | 739 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 2.70e-03 | 11 | 130 | 2 | 559 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | MYH10 CENPF SPTAN1 BRCA2 SUN2 CDC42BPA NUMA1 APC CEP192 SASS6 PCM1 PCNT | 7.90e-08 | 199 | 210 | 12 | M5893 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 MYO10 HAUS3 UPF3A EPB41L3 CEP170 OSBPL8 GOLGB1 NPM1 CDC42BPA APC CEP192 SMC2 OPA1 IWS1 RLF APPL1 CSPP1 PCM1 | 1.58e-06 | 656 | 210 | 19 | M18979 |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN | MYH10 DAB2 TRPM3 C7orf25 DNAH5 PCDHGC5 AFF3 DGKZ CALHM2 USP2 SLF2 ASCL1 | 2.88e-06 | 279 | 210 | 12 | M250 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.57e-05 | 180 | 210 | 9 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPF MYO10 ZNF804A CEP170 BRCA2 OSBPL8 TJP2 USP13 AMPH CDC42BPA IPO7 APC SIK3 OPA1 RLF UPF2 MACF1 TOP1 SAMD4A PCNT | 2.01e-05 | 856 | 210 | 20 | M4500 |
| Coexpression | PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP | 3.04e-05 | 110 | 210 | 7 | M41176 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 3.60e-05 | 200 | 210 | 9 | M9391 | |
| Coexpression | FISCHER_DREAM_TARGETS | CENPF ZGRF1 HAUS3 BCS1L NUP205 FANCC LONP1 CEP78 BRCA2 ANAPC1 PIGK CEP192 SMC2 OPA1 DARS2 SPAG5 SLF2 SASS6 CEP295 TOP1 PCNT | 3.73e-05 | 969 | 210 | 21 | M149 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | ACTN2 CACNA1B SEMG1 AMPH CECR2 ASCL1 LRRTM2 ADGRA1 MYOM2 PCNT | 4.90e-05 | 259 | 210 | 10 | M9331 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | MYH10 CENPF ZGRF1 ANKRD49 CEP170 BRCA2 GOLGB1 NPM1 PGS1 APC CHD7 SMC2 ZBTB1 IWS1 UPF2 SLF2 PDE8B MACF1 CEP295 CSPP1 CDH8 TOP1 PCM1 | 6.34e-08 | 629 | 208 | 23 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | MYH10 ERCC6 CENPF ANKRD49 IKZF1 ACTN2 LONP1 BRCA2 TJP2 GOLGB1 NPM1 PGS1 FOXP2 SYNE1 CECR2 APC CHD7 SMC2 ZBTB1 IWS1 SLF2 PDE8B SRGN MACF1 CEP295 SPRTN CSPP1 TOP1 PCM1 | 1.32e-07 | 989 | 208 | 29 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | MYH10 ANKRD49 BRCA2 GOLGB1 NPM1 PGS1 FOXP2 SYNE1 APC SMC2 ZBTB1 SLF2 SRGN MACF1 CEP295 TOP1 PCM1 | 1.35e-06 | 432 | 208 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CENPF ANKRD49 BRCA2 NPM1 IPO7 CEP162 CHD7 SPAG5 IWS1 ADGRA1 CEP295 TOP1 PCM1 | 1.29e-05 | 311 | 208 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ERCC6 CENPF SPTAN1 BRCA2 NPM1 USP13 IPO7 CHD7 CEP192 SMC2 ZBTB1 OPA1 SPAG5 IWS1 RLF TOP1 PCNT | 2.09e-05 | 532 | 208 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CENPF MYO10 IKZF1 ADGRV1 NEFL BRCA2 CECR2 APLP1 CHD7 SPAG5 IWS1 ASCL1 CEP295 CDH8 TOP1 PCM1 | 3.44e-05 | 498 | 208 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MYH10 CENPF MYO10 ZGRF1 ANKRD49 HAUS3 ADGRV1 UBN2 BRCA2 USP3 CNN1 NPM1 USP13 IPO7 FOXP2 CECR2 APC CHD7 CEP192 SMC2 SPAG5 IWS1 USP2 UPF2 SRGN SASS6 MACF1 CEP295 CSPP1 TOP1 PCM1 | 3.76e-05 | 1459 | 208 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CENPF ANKRD49 HAUS3 TUBGCP4 NEFL BRCA2 USP3 NPM1 LCA5 IPO7 FOXP2 CEP162 APC MPEG1 CHD7 CEP192 SMC2 SPAG5 USP2 SASS6 MACF1 CEP295 CSPP1 TOP1 PCM1 | 4.41e-05 | 1060 | 208 | 25 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 9.46e-05 | 186 | 208 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MYH10 CENPF MYO10 ZGRF1 ANKRD49 HAUS3 UBN2 BRCA2 USP3 CNN1 NPM1 USP13 IPO7 FOXP2 APC CEP192 SMC2 SPAG5 IWS1 USP2 UPF2 SASS6 MACF1 CEP295 CSPP1 TOP1 PCM1 | 1.05e-04 | 1257 | 208 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | CENPF MYO10 ADGRV1 BRCA2 NPM1 CECR2 CHD7 TFDP2 SPAG5 IWS1 ASCL1 SRGN ADGRA1 CDH8 TOP1 | 1.11e-04 | 493 | 208 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CENPF MYO10 ANKRD49 IKZF1 ACTN2 ADGRV1 NEFL BRCA2 NPM1 IPO7 CEP162 CECR2 APLP1 CHD7 SPAG5 IWS1 ASCL1 ADGRA1 CEP295 CDH8 TOP1 PCM1 PCNT | 1.12e-04 | 989 | 208 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.90e-04 | 204 | 208 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_200 | 2.02e-04 | 162 | 208 | 8 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CENPF HAUS3 BRCA2 NPM1 USP13 IPO7 APC CHD7 CEP192 SMC2 IWS1 RLF UPF2 TOP1 | 2.29e-04 | 469 | 208 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.58e-04 | 90 | 208 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k4 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000_k-means-cluster#5 | OBSCN ACTN2 MYLK3 PXDNL PCDHGC5 MPEG1 SLC26A9 CCDC141 USP2 MYOM2 NDRG4 ALPK2 CACNA2D3 | 2.97e-04 | 424 | 208 | 13 | geo_heart_1000_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CENPF ANKRD49 HAUS3 ADGRV1 TUBGCP4 ZNF804A NEFL BRCA2 USP3 NPM1 LCA5 IPO7 FOXP2 CEP162 CECR2 APC MPEG1 CHD7 CEP192 SMC2 SPAG5 USP2 SASS6 MACF1 CEP295 CSPP1 TOP1 PCM1 | 2.99e-04 | 1414 | 208 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN ADGRV1 TRPM3 TLN2 KIF5A DNAH5 KALRN APOB ARFGEF3 MYOM2 DNAH11 | 1.38e-09 | 184 | 211 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN ADGRV1 TRPM3 TLN2 KIF5A DNAH5 KALRN APOB ARFGEF3 MYOM2 DNAH11 | 1.38e-09 | 184 | 211 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN ADGRV1 TRPM3 TLN2 KIF5A DNAH5 KALRN APOB ARFGEF3 MYOM2 DNAH11 | 1.38e-09 | 184 | 211 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ACTN2 KCNB2 STARD9 CNN1 PITPNM2 KALRN SYNE1 USP2 MYOM2 CACNA2D3 DNAH11 | 2.99e-09 | 198 | 211 | 11 | c12e7511628db819a52959bb68580e27c00c2e41 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | SPTAN1 ITPK1 PDZD8 GOLGB1 SYNE1 NUMA1 MYO18A CPEB3 UPF2 DIP2C | 1.35e-08 | 177 | 211 | 10 | e8ab340b20cd41554c3841fe980e078e878af35f |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | KLHL24 OBSCN ACTN2 MYLK3 CCDC141 MYOM2 NDRG4 ALPK2 CACNA2D3 SAMD4A | 2.65e-08 | 190 | 211 | 10 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | MCIDAS NUP205 CEP78 CROCC2 DNAH8 SPAG5 PDE8B CCDC87 CEP295 PCNT | 2.79e-08 | 191 | 211 | 10 | 37cf121e6e80760c8519075b7845b9029958a988 |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | KLHL24 OBSCN ACTN2 MYLK3 USP13 CCDC141 MYOM2 NDRG4 ALPK2 SAMD4A | 2.93e-08 | 192 | 211 | 10 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CENPF MCIDAS CEP78 BRCA2 USP13 SMC2 CEP295 ANKRD36 PCM1 PCNT | 3.23e-08 | 194 | 211 | 10 | dff3fb10372053951d41e0ccd41aac3ece6009bd |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | OBSCN ACTN2 MYLK3 PXDNL USP13 CCDC141 MYOM2 NDRG4 ALPK2 SAMD4A | 3.39e-08 | 195 | 211 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ACTN2 KCNB2 STARD9 CNN1 PITPNM2 SYNE1 USP2 MYOM2 CACNA2D3 DNAH11 | 3.91e-08 | 198 | 211 | 10 | 22e766df1276c5b14aa0d83f434f47140ebb98ea |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.42e-08 | 157 | 211 | 9 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-07 | 134 | 211 | 8 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.73e-07 | 186 | 211 | 9 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.85e-07 | 187 | 211 | 9 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.12e-07 | 189 | 211 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-07 | 190 | 211 | 9 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-07 | 190 | 211 | 9 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.60e-07 | 140 | 211 | 8 | e4689232c473d239b07a7fbcaaa3414fbd9badea | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.60e-07 | 140 | 211 | 8 | 8abbd5dc799943b49cd0045d0da405c3f3d0db6b | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.72e-07 | 193 | 211 | 9 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ADGRV1 PITPNM2 USP13 FOXP2 SYNE1 AFF3 SLC26A9 CCDC141 ARFGEF3 | 3.89e-07 | 194 | 211 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.89e-07 | 194 | 211 | 9 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.06e-07 | 195 | 211 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.42e-07 | 197 | 211 | 9 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.42e-07 | 197 | 211 | 9 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-07 | 198 | 211 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.44e-07 | 154 | 211 | 8 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.44e-07 | 154 | 211 | 8 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.57e-06 | 170 | 211 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.64e-06 | 171 | 211 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.92e-06 | 122 | 211 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-06 | 175 | 211 | 8 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-06 | 176 | 211 | 8 | d54543510c804474c5c32e007cd699e75fc5aaba | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 177 | 211 | 8 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 178 | 211 | 8 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-06 | 179 | 211 | 8 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 180 | 211 | 8 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 180 | 211 | 8 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 180 | 211 | 8 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.50e-06 | 181 | 211 | 8 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 182 | 211 | 8 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-06 | 184 | 211 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-06 | 184 | 211 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.94e-06 | 185 | 211 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 187 | 211 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.31e-06 | 188 | 211 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.31e-06 | 188 | 211 | 8 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.44e-06 | 189 | 211 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 189 | 211 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.44e-06 | 189 | 211 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.58e-06 | 190 | 211 | 8 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.58e-06 | 190 | 211 | 8 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.58e-06 | 190 | 211 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.58e-06 | 190 | 211 | 8 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 191 | 211 | 8 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 191 | 211 | 8 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.72e-06 | 191 | 211 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 191 | 211 | 8 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.72e-06 | 191 | 211 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.87e-06 | 192 | 211 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.02e-06 | 193 | 211 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.02e-06 | 193 | 211 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 4.02e-06 | 193 | 211 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.18e-06 | 194 | 211 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 4.18e-06 | 194 | 211 | 8 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-06 | 195 | 211 | 8 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-06 | 196 | 211 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.51e-06 | 196 | 211 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 4.51e-06 | 196 | 211 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.68e-06 | 197 | 211 | 8 | 76304df40f87224f8e415677e3ee8fb183fe0c03 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.85e-06 | 198 | 211 | 8 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.85e-06 | 198 | 211 | 8 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | mild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.85e-06 | 198 | 211 | 8 | dce3c008757786aa6bd4a869456b76b4cbbb1d5b | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.85e-06 | 198 | 211 | 8 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new|World / Primary Cells by Cluster | 4.85e-06 | 198 | 211 | 8 | 11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0 | |
| ToppCell | control-Lymphocytic-NK_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.85e-06 | 198 | 211 | 8 | 1c779101d0c5f29de5cc7170d784931d6e34bdcd | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new-9|World / Primary Cells by Cluster | 4.85e-06 | 198 | 211 | 8 | c724ef958e14e17a7d8c02b9f842510c0780f635 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.85e-06 | 198 | 211 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 5.04e-06 | 199 | 211 | 8 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.04e-06 | 199 | 211 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 5.23e-06 | 200 | 211 | 8 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 5.23e-06 | 200 | 211 | 8 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 5.23e-06 | 200 | 211 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-06 | 151 | 211 | 7 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-06 | 155 | 211 | 7 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-05 | 165 | 211 | 7 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.40e-05 | 165 | 211 | 7 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 166 | 211 | 7 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 166 | 211 | 7 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 169 | 211 | 7 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 172 | 211 | 7 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 172 | 211 | 7 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-05 | 173 | 211 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-05 | 175 | 211 | 7 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-05 | 175 | 211 | 7 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 121 | 211 | 6 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.46e-05 | 180 | 211 | 7 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 181 | 211 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 181 | 211 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | CDK18 UPF3A LRIG2 TRPM3 SUN2 KCNS1 MUL1 CA1 PGS1 ASCL1 MACF1 | 2.43e-06 | 198 | 210 | 11 | 169_DN |
| Disease | thyroid nodule | 4.95e-05 | 2 | 208 | 2 | EFO_1001436 | |
| Disease | Phlebitis | 4.95e-05 | 2 | 208 | 2 | EFO_1001395 | |
| Disease | Primary ciliary dyskinesia | 1.18e-04 | 36 | 208 | 4 | cv:C0008780 | |
| Disease | Cockayne Syndrome | 1.48e-04 | 3 | 208 | 2 | C0009207 | |
| Disease | Malignant neoplasm of breast | ERCC6 CENPF SPTAN1 OBSCN EPB41L3 BRCA2 HERC2 GOLGB1 PGBD3 KALRN SYNE1 SIK3 TRMT2A MTOR DIP2C MACF1 APPL1 CYB5R4 TOP1 | 2.32e-04 | 1074 | 208 | 19 | C0006142 |
| Disease | Kartagener syndrome (is_implicated_in) | 2.94e-04 | 4 | 208 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | age at menopause | 3.13e-04 | 302 | 208 | 9 | EFO_0004704 | |
| Disease | Primary Ciliary Dyskinesia | 3.37e-04 | 47 | 208 | 4 | C4551720 | |
| Disease | Intellectual Disability | GALT MCC TRPM3 KIF5A CACNA1B SYNE1 AFF3 APC MTOR ASCL1 MACF1 | 3.58e-04 | 447 | 208 | 11 | C3714756 |
| Disease | uric acid measurement | PCNX3 BCAS3 ADGRV1 EPB41L3 ITPK1 SELENOO CDC42BPA TFDP2 USP2 DIP2C ARHGEF26 SNX1 CACNA2D3 | 4.23e-04 | 610 | 208 | 13 | EFO_0004761 |
| Disease | red blood cell density measurement | BCAS3 IKZF1 ADGRV1 NUP205 CEP78 TRPM3 TJP2 USP3 KALRN AFF3 CAPZA2 SIK3 KLHL25 FAM13A PDE8B TOP1 | 5.43e-04 | 880 | 208 | 16 | EFO_0007978 |
| Disease | hearing impairment | 6.62e-04 | 98 | 208 | 5 | C1384666 | |
| Disease | mean platelet volume | PCNX3 IKZF1 TRPM3 KCNS1 CHMP4C PITPNM2 PCDHGC5 KALRN PCDHGA1 AFF3 CAPZA1 CAPZA2 NUMA1 CHD7 SIK3 FAM13A ARHGAP45 | 9.61e-04 | 1020 | 208 | 17 | EFO_0004584 |
| Disease | Rectal Neoplasms | 1.01e-03 | 7 | 208 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 1.01e-03 | 7 | 208 | 2 | C0007113 | |
| Disease | Ciliopathies | 1.12e-03 | 110 | 208 | 5 | C4277690 | |
| Disease | FEV/FEC ratio | BCAS3 MCC ITPK1 ANAPC1 CROCC2 DCAF17 DNAH5 USP3 ZNRD2 PCDHGA1 AFF3 SLC26A9 PABPC4L FAM83H SLC51B KLHL25 FAM13A ARHGEF26 CACNA2D3 | 1.17e-03 | 1228 | 208 | 19 | EFO_0004713 |
| Disease | squamous cell carcinoma | 1.30e-03 | 67 | 208 | 4 | EFO_0000707 | |
| Disease | Drug habituation | 1.36e-03 | 115 | 208 | 5 | C0013170 | |
| Disease | Drug abuse | 1.36e-03 | 115 | 208 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.36e-03 | 115 | 208 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.36e-03 | 115 | 208 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.36e-03 | 115 | 208 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.36e-03 | 115 | 208 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.36e-03 | 115 | 208 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.36e-03 | 115 | 208 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.36e-03 | 115 | 208 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.41e-03 | 116 | 208 | 5 | C0740858 | |
| Disease | carotid artery intima media thickness | ZNF804A NEFL TLN2 PCDHGA1 CEP170P1 APOB CHD7 FAM13A CDH8 DNAH11 | 1.42e-03 | 450 | 208 | 10 | EFO_0007117 |
| Disease | creatinine measurement, chronic kidney disease | 1.91e-03 | 35 | 208 | 3 | EFO_0003884, EFO_0004518 | |
| Disease | aspartate aminotransferase measurement | OBSCN DAB2 IKZF1 TRPM3 KIAA2012 PGS1 B3GNTL1 KALRN KLHL25 FAM13A TMEM132D MTOR ARHGAP45 ALPK2 SAMD4A | 1.98e-03 | 904 | 208 | 15 | EFO_0004736 |
| Disease | urea measurement | 2.14e-03 | 10 | 208 | 2 | EFO_0011005 | |
| Disease | medulloblastoma (is_implicated_in) | 2.14e-03 | 10 | 208 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 2.14e-03 | 10 | 208 | 2 | OBA_2045163 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.14e-03 | 10 | 208 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.25e-03 | 37 | 208 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | basal cell carcinoma | 2.29e-03 | 189 | 208 | 6 | EFO_0004193 | |
| Disease | breast carcinoma | BCAS3 EPB41L3 BRCA2 PXDNL SPIC B3GNTL1 CEP162 CPEB3 LAMB2 CEP192 SIK3 SMC2 CCDC87 PCM1 PCNT DNAH11 | 2.46e-03 | 1019 | 208 | 16 | EFO_0000305 |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 2.61e-03 | 11 | 208 | 2 | EFO_0009923 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 2.61e-03 | 11 | 208 | 2 | OBA_2045170 | |
| Disease | Lewy body dementia | 2.62e-03 | 39 | 208 | 3 | EFO_0006792 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.73e-03 | 82 | 208 | 4 | EFO_0008535 | |
| Disease | pain | 2.75e-03 | 196 | 208 | 6 | EFO_0003843 | |
| Disease | high grade glioma (is_marker_for) | 3.24e-03 | 42 | 208 | 3 | DOID:3070 (is_marker_for) | |
| Disease | IGFBP-1 measurement | 3.66e-03 | 13 | 208 | 2 | EFO_0005118 | |
| Disease | Benign tumor of pancreas | 3.66e-03 | 13 | 208 | 2 | C0347284 | |
| Disease | gallbladder cancer (is_implicated_in) | 3.66e-03 | 13 | 208 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | serum IgG glycosylation measurement | CDK18 IKZF1 ZNF804A SUN2 GOLGA5 CNN1 FOXP2 TMEM132D ZNF804B DHX34 | 4.18e-03 | 523 | 208 | 10 | EFO_0005193 |
| Disease | skin melanoma (is_implicated_in) | 4.26e-03 | 14 | 208 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | inositol measurement | 4.26e-03 | 14 | 208 | 2 | EFO_0010504 | |
| Disease | Fanconi anemia | 4.26e-03 | 14 | 208 | 2 | cv:C0015625 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.26e-03 | 14 | 208 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ERCC6 OBSCN MCC KCNB2 ZNF804A MYLK3 DNAH8 KALRN SYNE1 APC APOB DIP2C | 4.35e-03 | 702 | 208 | 12 | C0009402 |
| Disease | forced expiratory volume, response to bronchodilator | 4.52e-03 | 445 | 208 | 9 | EFO_0004314, GO_0097366 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.89e-03 | 15 | 208 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 4.89e-03 | 15 | 208 | 2 | C0154017 | |
| Disease | triacylglycerol 52:3 measurement | 4.89e-03 | 15 | 208 | 2 | EFO_0010415 | |
| Disease | Carcinoma in situ of bladder | 4.89e-03 | 15 | 208 | 2 | C0154091 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.30e-03 | 50 | 208 | 3 | EFO_0022247 | |
| Disease | 5-oxoproline measurement | 5.56e-03 | 16 | 208 | 2 | EFO_0010988 | |
| Disease | cutaneous Leishmaniasis | 5.56e-03 | 16 | 208 | 2 | EFO_0005046 | |
| Disease | Polyposis, Adenomatous Intestinal | 5.56e-03 | 16 | 208 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 5.56e-03 | 16 | 208 | 2 | C2713443 | |
| Disease | gastroesophageal reflux disease | 5.75e-03 | 101 | 208 | 4 | EFO_0003948 | |
| Disease | Heschl's gyrus morphology measurement | 6.24e-03 | 53 | 208 | 3 | EFO_0005852 | |
| Disease | Lipidemias | 6.27e-03 | 17 | 208 | 2 | C1706412 | |
| Disease | Adenomatous Polyposis Coli | 6.27e-03 | 17 | 208 | 2 | C0032580 | |
| Disease | Hyperlipidemia | 6.27e-03 | 17 | 208 | 2 | C0020473 | |
| Disease | waist-hip ratio | DAB2 MCC KCNB2 NUP205 OPTC PDZD8 MED27 USP3 AFF3 CPEB3 CEP192 SIK3 FAM13A MEGF8 PDE8B ARHGEF26 TOP1 | 6.31e-03 | 1226 | 208 | 17 | EFO_0004343 |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 6.32e-03 | 307 | 208 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | Small cell carcinoma of lung | 6.58e-03 | 54 | 208 | 3 | C0149925 | |
| Disease | cholesterol to total lipids in large HDL percentage | 6.92e-03 | 55 | 208 | 3 | EFO_0022234 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 7.02e-03 | 18 | 208 | 2 | C0342384 | |
| Disease | Bone marrow hypocellularity | 7.02e-03 | 18 | 208 | 2 | C1855710 | |
| Disease | Carcinoma of bladder | 7.02e-03 | 18 | 208 | 2 | C0699885 | |
| Disease | disease free survival | 7.02e-03 | 18 | 208 | 2 | EFO_0000409 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKIDEHFVADSRAQN | 106 | P51826 | |
| ENAESEADFSIHFNR | 1556 | Q5SW79 | |
| SEDFVILANRENHKN | 381 | Q5H9S7 | |
| DLGDLNESDFLNNAH | 21 | Q96BA8 | |
| AFESDLAAHQDRVEQ | 446 | P35609 | |
| QDRLLAQDSEHNHSD | 456 | P54284 | |
| NNSASDLHEISNEIL | 2526 | Q8IZF6 | |
| DSHQAREEFASDNLL | 471 | Q86TB3 | |
| SLAEFTEQFNQLHNR | 26 | Q07002 | |
| LAENFAEHVLRATNQ | 376 | Q9Y276 | |
| NNDNLLREGAAHAFA | 41 | P52907 | |
| NGDLNQFLSAHQLED | 706 | Q08345 | |
| NSTAHAQQNLDFIDL | 311 | Q8WXG9 | |
| NFLLHVDNQATENED | 3821 | Q8WXG9 | |
| LQNEHSFQAQLRAAA | 246 | Q86SQ6 | |
| DRQALNEHFQSILQT | 346 | P51693 | |
| ANHNDSRVTLFEGDN | 101 | P53672 | |
| HQASLDVNNPRDFID | 251 | P10632 | |
| ADLQFEDNQDVSAHR | 1661 | Q96DT5 | |
| ASQEAELQLRNHDAE | 3121 | Q96DT5 | |
| LEARHQNNIFIDDIS | 501 | Q96DR7 | |
| DQSHSSKRDQELAFQ | 1616 | A6QL64 | |
| AVSHEQLAQLREDNT | 1036 | Q8IYA2 | |
| ELEHENAQLRNINFS | 486 | Q5JTW2 | |
| RNHFSLFSAENEALD | 861 | Q96M86 | |
| QQLQEAARDHSSVVA | 1096 | Q8TF21 | |
| QHLADSKNDNDNIFL | 96 | P01008 | |
| NLSSSHFLEENQVRS | 756 | Q9NVE4 | |
| ENADLNDTSRNLEFH | 66 | Q9H6U6 | |
| LDDDTSINRHNNFRT | 1626 | Q00975 | |
| ELSFLDAHKNFAQNR | 2121 | Q9P2D1 | |
| FQREALENSHTNTEV | 91 | Q96CF2 | |
| FLDLDNHNAATKRQS | 1316 | Q9BXF3 | |
| HDFEAANSDELTLQR | 631 | P49418 | |
| FKVDNDENEHQLSLR | 31 | P06748 | |
| HVFSEADAEQDNQRA | 706 | Q6ZP01 | |
| DNQRAHDVDVSSNLK | 716 | Q6ZP01 | |
| FFQTDLQLTDINDHA | 116 | Q9Y5E4 | |
| QNSDIVFAENLSRHF | 46 | Q96LU5 | |
| NLNASDSESEELHRQ | 76 | Q96ST2 | |
| IQEDHLRASFLQDSQ | 216 | Q2M385 | |
| SQHDLDQLQADAINA | 1956 | Q92621 | |
| LLFEAQHSQRSLQDA | 466 | Q8N149 | |
| LQVEQEENRFSFRHS | 906 | Q9H1A4 | |
| ETIFSNLHVADNANL | 691 | P0DP91 | |
| QTEAVTFLANHDDSR | 151 | Q9Y2S7 | |
| NADHDDFDANQLLNK | 696 | P98082 | |
| NHITELERDQFASFS | 71 | O43300 | |
| EADQNDSQSLELVHR | 66 | Q13572 | |
| HLSFLEQQQSEASLE | 1051 | Q92619 | |
| RAEDHFSVIDFNQNI | 341 | P19823 | |
| QHVNDRTFFIDASNQ | 21 | A6NIV6 | |
| DHSQAFLQAIADNNI | 1386 | O95714 | |
| ALQTFQERLHEADAT | 346 | Q8TBA6 | |
| EVFQIASNDHDAAIN | 131 | Q9UKG1 | |
| NEDQLFQRTAEVHSR | 226 | Q9HA72 | |
| FLLQRFEDHQAAINN | 371 | Q6X9E4 | |
| FEHDARIQALALSQD | 296 | Q8N3Y1 | |
| NFERETHKISEQNDA | 1476 | Q15154 | |
| DDNNLNSIFYEHLTR | 1381 | A6NKB5 | |
| DDNNLNSIFYEHLTR | 1336 | Q9H6A9 | |
| AAERQLNEAHKSLNF | 21 | O95373 | |
| SIDNDAFRLLHALQD | 191 | Q9UBM4 | |
| ANTSLHVFVLDENDN | 546 | Q9Y5F6 | |
| RRFDSELSQAHEEAQ | 1461 | Q92614 | |
| QQDAAQHGARLEALF | 101 | Q32MK0 | |
| FHSNSLLTQEDAAAA | 326 | Q32NB8 | |
| RAQNEFKDEAQSLSH | 506 | Q8NEN9 | |
| VIDHRQTQNFDAEAV | 181 | O95263 | |
| TFQNVHDFNELKDRD | 1006 | Q1MSJ5 | |
| DFSASVQFIQNHLDE | 4081 | Q96JB1 | |
| HLNNEHALDDRSTAQ | 366 | O15409 | |
| LQKRHDDFEEVAQNT | 576 | O60229 | |
| ADSQGLLFFRQDQAH | 2631 | Q7Z7M0 | |
| DLFEHVSSRNNQDTL | 586 | Q9HD67 | |
| LFSQETSANISHERD | 816 | Q0VF49 | |
| QEEFQEHEAQLLSRA | 276 | Q969V5 | |
| VQDENFNANHALSGL | 1286 | P55268 | |
| EDAENEISQLIFRHN | 151 | Q86VQ0 | |
| GLLDNHSSEFNVTRN | 446 | P36776 | |
| FSQLLHQINSTRDFE | 541 | Q9UGJ1 | |
| FAAQLRAQISDDTTH | 6 | Q14390 | |
| EAAVRNSNHQEFEDL | 471 | Q96KK3 | |
| NSNHQEFEDLLSSID | 476 | Q96KK3 | |
| NSLDFSEHFNQLELL | 16 | Q8WVL7 | |
| SNHSAQDSAVENLLL | 361 | Q13422 | |
| FQDNLHSVNRDLNEL | 56 | Q6P2C8 | |
| VTANHRINDALANED | 1001 | Q9BZ72 | |
| LSQIFSDENNHLSSR | 376 | Q3MIN7 | |
| SDENNHLSSREILFQ | 381 | Q3MIN7 | |
| RSAVEQHLFDVNNSG | 371 | O94988 | |
| QDAFLQEAQEQHARE | 886 | O95613 | |
| AASHIEDQAEQFFRS | 26 | Q92643 | |
| SHQTEADFNLQDFRD | 106 | D6RGH6 | |
| HTQEDLQQLRSDLDA | 1096 | Q9UPN3 | |
| HSSFLQELQQCDTDD | 5751 | Q5VST9 | |
| GDNFQLNDSEIERQH | 306 | Q9BZF1 | |
| LNDSEIERQHFKDQD | 311 | Q9BZF1 | |
| DFAEDSLRVIQHNAL | 716 | O60313 | |
| NHSLDLEDDTRLNVF | 271 | A1KZ92 | |
| NTNAELFNQSDIVAH | 3351 | P04114 | |
| SEIRHQQSAEFVNDL | 751 | P23508 | |
| SSHAENILQIFNEFR | 46 | Q6TFL4 | |
| TDEFGQLNDNRQLAH | 221 | Q92953 | |
| ESRDDTVNFQDNLHP | 81 | Q9H0H3 | |
| ADNNFTKTQDRLHAS | 1351 | Q6ZP82 | |
| FKSNEHSDQLTREEN | 2016 | P51587 | |
| TNEDHQRSLLAFDQQ | 776 | P49454 | |
| LNNAFLDDSHGDQAL | 406 | Q8NE35 | |
| QQLLDEHDAVSAAFQ | 171 | P50553 | |
| ALNEAFNILSDFNHT | 341 | Q8IZS8 | |
| QDLTAQHQRDLATEA | 1576 | H7BZ55 | |
| SFHVNFEDNDNRSVL | 66 | P00915 | |
| SIIEQAEDFLQASHQ | 141 | Q9BPX7 | |
| EADAAAATFRANDHQ | 16 | P07902 | |
| QEADQHSARLFIQSL | 666 | Q5TH69 | |
| SLASELRENHLNGFN | 156 | Q00597 | |
| FAHNLAQAQRLQEED | 66 | P56202 | |
| QNERELFEQAAEQHS | 226 | Q5JW98 | |
| DESLQSDHFNSRLSF | 1391 | Q9Y2E4 | |
| QDQLAVSAQEHSFFL | 486 | Q68CZ6 | |
| NAESEADFSIHFNRV | 266 | Q96L14 | |
| SQDSQHVNLFFDKND | 396 | Q5TB80 | |
| NHRDSRLTIFEQENF | 101 | P53673 | |
| DVKLNSDNFHDANAN | 366 | Q8TEP8 | |
| VQRELSHLQSENDAA | 466 | Q12840 | |
| RHTDLERQFNINADD | 431 | P55286 | |
| QDSFQSQDLDRNQHF | 356 | Q8NDH2 | |
| AQDTELAAYLENRQH | 901 | Q13574 | |
| LDLRDSFAQQLHQEA | 791 | Q6ZRV2 | |
| AQRIDSDDALNHDFF | 301 | P50750 | |
| SSDEANVFDQLNVQH | 2241 | Q9C0D2 | |
| RHDLAQLQAAASSAQ | 776 | Q14147 | |
| ANASLQDILSHRFNE | 91 | Q9Y226 | |
| QNLFSNSDHQRDGTL | 616 | Q6UVJ0 | |
| QQQALEQFAAAAAHS | 41 | Q9Y2J2 | |
| DLTVDLDHQRQVASN | 1431 | P35580 | |
| DFNATVQFIQNHLDD | 4216 | Q8TE73 | |
| ALLNNSNAEDSFLRE | 96 | Q8N309 | |
| ATRQDHAQQLATAAE | 576 | Q14980 | |
| DEAKDHNSLNNLRET | 81 | Q86UW2 | |
| FVHFQNQSAADRAIE | 141 | P0CB38 | |
| ITEQQRDSLSHDFNG | 181 | Q9HAU5 | |
| IFSVRAHDLDSNENA | 471 | Q9Y5H4 | |
| RFETIFSNLHVADNA | 221 | Q8N328 | |
| ERFDAHLAQAENLQA | 681 | P42345 | |
| HNNRVFTDSEELASA | 996 | Q5VT97 | |
| SIRNFAADHFNQEIL | 386 | Q6PI48 | |
| RVNAQDNELSNVEFH | 471 | Q8IZ69 | |
| ELAEHQAIDQAHSNA | 316 | Q96M34 | |
| ETLEFADQENQVAHL | 801 | Q96R06 | |
| AENISNLDNHLRAEE | 2221 | Q8NF91 | |
| TELLENHINFASSQD | 971 | Q14C87 | |
| HDAVLFAQANARDVT | 731 | Q7LBE3 | |
| HNNEAQQAIISALDD | 471 | Q96NG3 | |
| LHDNLSDLRAQVAAN | 916 | O14841 | |
| LSALEVQFHRDSQQQ | 26 | Q9H1J1 | |
| RSTQVNFFDDDNHRQ | 3001 | Q96Q15 | |
| QEDDSDRHLAQHLNN | 441 | P04279 | |
| QAAHASDSVQRNAAF | 296 | Q9BVL4 | |
| SADSAEAHSLNVNRF | 866 | Q9Y2K2 | |
| RQAEEADEQANAHLT | 1881 | P11055 | |
| LSHLFSQEELVNNTE | 166 | Q9ULP0 | |
| LKNAQAHRSADEANV | 826 | Q5C9Z4 | |
| NRFAVALDSEQNNIH | 581 | O00267 | |
| SLFIHENNEKNDRDR | 176 | Q8IX21 | |
| QFSTELRDHNRLDSQ | 3176 | Q9P2P6 | |
| QAFEDAFEVLRQHST | 11 | Q8N5J4 | |
| NLDSIIVDHQNDSFR | 191 | Q7L1T6 | |
| SSHLEQQLEEANAVR | 506 | Q5VT25 | |
| SLQAAAILDANDAHQ | 526 | Q9UHB9 | |
| DELVSEFTNSNNHLA | 156 | Q14188 | |
| ADVQSQLRHIEAAFD | 506 | Q15437 | |
| NAEENAAEFLKQHNS | 261 | P53597 | |
| NFNSAHDTDRNLSVD | 296 | Q08188 | |
| AFEDNLRSLHLQEGQ | 341 | Q67FW5 | |
| NNDNLLREGAAHAFA | 41 | P47755 | |
| AQHLSETFDNIDNLS | 766 | P25054 | |
| NSLAAQHFESQQDLE | 191 | Q9NQ89 | |
| FEANDLFENTNHTQV | 106 | P51911 | |
| NQEVRFDESNRLATH | 531 | Q8NE01 | |
| QAAFEHTTQLAEAQE | 216 | Q6UE05 | |
| LNRHATEFDAAQVLQ | 741 | Q8WUH2 | |
| AHLFTATINLNSAND | 851 | Q9UDY2 | |
| STNEHELFQEAENAL | 386 | Q6ZU65 | |
| TNNFTILADTDCDNH | 1011 | A4D1E1 | |
| QEELSALRAEHQQDS | 356 | Q9UH99 | |
| SLQESHDALLEFGNN | 156 | Q13129 | |
| HQEQANNDFFLLAEL | 381 | Q13596 | |
| QALSLNTEEDIHRAF | 56 | P50453 | |
| TVNAQADRAFQQLEH | 241 | Q9H0U9 | |
| VDDISQELNHNSRDF | 711 | Q9HCF6 | |
| SSAQADFNQLAELDR | 2141 | Q13813 | |
| QLVDESDAFHDNLRS | 121 | P10124 | |
| QELSSEFEHLNQFLD | 181 | A6NK02 | |
| EFEHLNQFLDREQQA | 186 | A6NK02 | |
| AIDTHNQNDLTFRVS | 196 | Q9BTF0 | |
| DANTANNFLLISDDL | 191 | O75678 | |
| NLREQHDALEFFNSL | 1681 | O00507 | |
| EESFTTLNVDIRNHQ | 1736 | O00507 | |
| EALAAAQQHFNAVSA | 371 | O95347 | |
| NLQEAERDHAQESLS | 16 | Q9H040 | |
| ALNAQAALSQAREHQ | 86 | O60232 | |
| HNREADEESLQLGNF | 171 | Q9Y2K1 | |
| EHLQNLENSAFTADR | 116 | Q9Y6I4 | |
| IERDNSFHNVAEATF | 1926 | Q86YA3 | |
| NAENSETFADHRENI | 2006 | Q9Y4G6 | |
| LDLREFASENTNHAV | 526 | O75604 | |
| LHNDSQIEADFRLND | 6 | P11387 | |
| EHLEDQTTARNTFQE | 306 | Q9UPU9 | |
| NLSNSEEIHSDFQTL | 81 | P48595 | |
| SSNRQQDAQEFFLHL | 441 | Q92995 | |
| SELFNQDDFHLLENI | 906 | Q9NYU2 | |
| HNNFLDNNEATDINA | 86 | Q8TAF7 | |
| SDESLNRQNHLPEEF | 781 | Q7Z570 | |
| SSLQNSRDHANEELD | 2741 | Q14789 | |
| QDHAFDFSRTRNIQD | 1046 | O94898 | |
| NHQRSLDLSGQAFDE | 1311 | P54296 | |
| LENHIQTQSSALDRF | 146 | P0CAP1 | |
| FASFIERVHELEQQN | 101 | P07196 |